pso hns 59 annual convention & 1 philippine international ... · messages v y- v ^ ... people...

PSO-HNS 59th Annual Convention & 1st Philippine International ORL-HNS Congress


CONTENTS

Messages 03-08

1st Philippine ORL-HNS Congress 09

PSO-HNS Board of Trustees 2015 10

Organizing Committee 2015 11

Conference Guidelines 12

Vicinity Map 13

Floor Map 14

Pre-Congress Conferences 15

Program at a Glance 16-18

Program of Activities 19-27

Abstracts (Plenary) 28-35

Abstracts (Symposium) 36-58

Foreign Speakers’ Directory 59-60

Local Speakers’ Directory 61-62

Sponsors’ & Exhibitors’ Directory 63-68

Sponsors & Exhibitors Booth Layout 69-70

Acknowledgement 71


MESSAGES

BENIGNO S. AQUINO III

President

Republic of the Philippines

MAN I L A

30 November 2015

M y warmest greetings to the Philippine Society of

Otolaryngology - Head & Neck Surgery as you

hold your 59th Annual Convention and 1st

Philippine International ORL-HNS Congress.

Humanity has made much progress in the spirit of innovation and scientific inquiry: Your twin events reveal

the significance of continuing research in upholding excellence amidst today’s rapidly shifting milieu, as you

update with recent developments and further push the frontiers of the local practice of otolaryngology. May

these discussions refine your expertise and skills, and empower you to address the dynamic needs of our

people that you may lengthen our collective strides towards establishing Universal Healthcare.

The Philippines of today is a far cry from the Sick Man of Asia that it once was. Buoyed by a renewed

bureaucracy, a revitalized landscape, and a determined, productive populace, we can scale even greater

heights. Let us sustain our efforts, build upon our momentum, and soar towards the brighter, more equitably

progressive future we have long aspired for.

I wish you engaging and galvanized gatherings.

MALACAÑAN PALACE MANILA


MESSAGES

JANETTE LORETO - GARIN, M.D.

Secretary of Health

W armest greetings to the Philippines Society of Otolaryngology - Head and Neck

Surgery (PSO-HNS) on the occasion of your 59th Annual Convention and the 1st

Philippine International ORL-HNS Congress with the theme “#Head&Neck: Be

Connected, Otolaryngology in the Age of Information Technology.”

In This occasion, PSO-HNS hosts distinguished local and foreign experts on otolaryngology, who shall

provide delegates information on the latest innovations as well as effective tools and techniques in the

ENT practice. May the sessions and dialogues in the congress in the congress help in improving

knowledge and skills of our specialists.

May PSO-HNS achieve the objectives and intended results of this remarkable undertaking. May your

fellowship strengthen camaraderie among the members for the advancement of the society’s mission and

vision, and excellence in the profession. Congratulations and Mabuhay!

Republic of the Philippines

Department of Health

OFFICE OF THE SECRETARY


MESSAGES

I convey my heartfelt greetings and congratulations to the

organizers of the Philippine Society of Otolaryngology-Head

and Neck Surgery (PSO-HNS) as you hold your 59th Annual

Convention and the 1st Philippine International ORL-HNS

Congress with the theme: “#Head&Neck Be Connected: Otolaryngology in the Age of Information

Technology”.

The efforts of the PSO-HNS to work towards the goal of advancing the field of otolaryngology-head and

neck surgery through one encompassing gathering, is truly admirable. The unity displayed by members of

your organization speaks of how even in the most complex of issues in the global health milieu we can

discover our respective niches and contribute significantly in creating effective, lasting solutions.

The Philippine Medical Association (PMA) is honored to be a part of your distinguished work, and as

President, I urge you to continue harnessing, along with your knowledge and capabilities, your diligence

and passion in building healing and comforting environs for your patients. As the umbrella organization

of all medical organizations in the Philippines, the PMA shares your aspirations for the consummate

Filipino medical professional who is equipped with not only the needed wisdom or skills to heal and ease

the patient’s malady, but also of a relentless yearning to push the boundaries of science and of oneself.

May this event inspire excellence in all of you, and strengthen your core as an organization that constantly

strive for advancement and the highest standards of our profession.

I send my fondest wish for a fruitful and memorable Convention for all the delegates. Mabuhay and

Cheers!

"PMA: Empowering the Filipino Physician for Nation Building"

MARIA MINERVA P. CALIMAG, M.D., PhD, FPBA

President

Philippine Medical Association


MESSAGES

ARMANDO M. CHIONG JR., M.D. President

Philippine Society of Otolaryngology-Head & Neck Surgery

M abuhay! With much sincerity and pride, I am inviting

all of you to attend the 59th Annual Convention and let

us become part of history by participating in the 1st

Philippine International ORL - HNS Congress! The

theme for this year is one that is both interesting and relevant for us -

#Head&Neck: Be Connected “Otolaryngology in the Age of Information

Technology.

As we live and practice in a globalized world, experiencing numerous advances in technology and research,

we are called to continue to become relevant in such a context. It is about time to be updated of the innovative

new effective tools and techniques that can be of benefit for our patients, that can be applied in our beloved

subspecialties. As ENT practitioners we must adapt and immense ourselves with the new opportunities that

technology can provide to us. Thus, we, the members of the PSO - HNS and its associates have to make the

necessary initiatives, and attending this program will be a good first step.

Assisting us in this 1st step would be my colleague Dr. Melfred Hernandez, the overall chair of the

organizing committee. Also, the contribution and efforts of the reliable head of the subcommittees with their

respective members would be a significant factor in making this convention a huge success. Not to be

outdone are our sponsors and exhibitors that are always here to help us in our endeavours.

As a final word, I would like to express my deepest gratitude to the present Board of Trustees who have been

supportive of me during my tenure. Also, the same can be said to all my co-fellows of the PSO - HNS for your

past support in attaining and realizing the vision and objectives of the society. Thus, I would like to implore

all of you again show your support in this last major PSO - HNS program of the year, as well as my tenure as

your president. May the Lord be with us always and take care all of us!


RODOLFO P. NONATO, M.D.

President

Philippine Board of Otolaryngology-Head & Neck Surgery

MESSAGES

T he Philippine Board of Otolaryngology - Head and Neck Surgery greets and congratulates

the officers and organizing committee of the Philippine Society of Otolaryngology - Head

and Neck Surgery in this annual convention with the theme “#Head&Neck Be Connect-

ed, Otolaryngology in the Age of Information Technology.”

We anticipate it to be another successful event specially with the line up of high quality speakers. The

influence of information technology in our specialty cannot anymore be denied. It has become part of our

everyday life. The topics will surely be very interesting and a learning experience for the delegates

regardless of what generation one belongs.

However, I also hope every one will participate and enjoy the social events with renewal of friendship and

fellowship which customary in our annual convention.

Thank you and mabuhay.


MESSAGES

MELFRED L. HERNANDEZ, M.D. Overall Convention Chair

PSO-HNS 59th Annual Convention

T o me it is to be called just the sharp sign, or the number sign,

or even the pound sign. But the hashtag?

(A hastag is a type of label or metadata tag used on social

network and micro blogging services, which makes it easier

for users to find messages with a specific theme or content. Users create and

use hashtags by placing the hash character (or number sign)# in front of a

word or unspaced phrase, either in the main text of a message or at the

end—Wikipedia)

I was one of the few remaining dinosaurs who did not and could not relate to the hashtagging phenomenon.

For the longest time, I resisted the enigma and the lure of it. But when I did succumb to the eventuality of it,

when I allowed myself to not resist and finally #Beconnected, it opened up a whole new world.

This hastagging world we now live in is one of interconnectivity, of universality, of bridging and shattering

barriers of time and distance and space. This year, we hope to bring this into our own little niche here at the

59th Annual Convention of the Philippine Society of Otolaryngology - Head and Neck Surgery and 1st

Philippine International ORL - HNS Congress.

Suddenly, our own little niche is not so little anymore. What with this new home - a sparklingly new,

humongous, pillar less, 3,000 square meter grand ballroom.

Welcome to the world of Otolaryngology in the Age of Information Technology.

#littlenichenotsolittleanymore #Head&Neck #BeConnected #59thpsohnsannualconvention


1st Philippine International ORL-HNS Congress

T he first Philippine International ORL-HNS Congress will be held from

November 30 - December 3, 2015 at the Marriott Grand Ballroom,

Newport City Complex. Being at the threshold of ASEAN integration in

2015, this congress highlights the globalized and international character of

the Filipino ENT practitioners’ training and perspective, while retaining the continuing

quest for local relevance. Topics to be covered will endeavour to emphasis emerging

trends, issues and controversies that challenge and beset the Filipino ENT specialists as

well. Opinion leaders and world renowned experts in the different sub-specialty fields of

otolaryngology - head and neck surgery will grace this historic congress in a show of

solidarity with the Philippine Society of Otolaryngology - Head and Neck Surgery, as it

looks back at its humble beginnings but leapfrogs to a great new future at par with the

world’s best.


BOARD OF TRUSTEES 2015

BOARD OF TRUSTEES

Armando M. Chiong Jr., MD

President

Melfred L. Hernandez, MD

Vice President

Ramon V. Carmona, MD

Secretary

Elmo R. Lago, MD

Treasurer

Christopher Malorre E. Calaquian, MD

Auditor

Ruben Emil D. Henson III, MD

Nelson G. Magno, MD

Danilo A. Poblete, MD

Joel A. Romualdez, MD

Gina M. Seredica, MD

Trustees

Howard M. Enriquez, MD

Immediate Past President

Rodolfo P. Nonato, MD

President, PBO-HNS

CHAPTER PRESIDENTS

Chester Rosario J. Puño, MD

Northern Luzon

Nelson N. Magno, MD

Central Luzon

Arvin L. De Jesus, MD

Southern Tagalog

Melvin G. Berin, MD

Bicol

Camille Sidonie A. Espina, MD

Central Eastern Visayas

Herman Melvin P. Sirilan, MD

Western Visayas

J. Gabriel C. De Borja, MD

Southern Mindanao

Vincent Mark M. Jardin, MD

Northern Mindanao


59th ANNUAL CONVENTION ORGANIZING COMMITEE

Armando M. Chiong Jr., MD

Honorary Chair

Melfred L. Hernandez, MD

Overall Convention Chair

Christopher Malorre E. Calaquian, MD

Secretary General

SCIENTIFIC COMMITTEE BLOCK

Teresa Luisa Gloria-Cruz, MD

Chair

Christine Joy S. Arquiza, MD

Kathrina B. Aquino - Diaz, MD

Ma. Lourdes Berioso-Enecilla, MD

Arsenio Claro A. Cabungcal, MD

Samantha S. Castaneda, MD

Philip B. Fullante,, MD

Agnes T. Remulla, MD

SUBSPECIALTY COORDINATORS

AHNOP: Mamerto G. Almelor, MD

PAAUD: Howard M. Enriquez, MD

PACMFS: Joselito F. David, MD

PAFPRS: Jaime Anthony A. Arzadon IV,MD

PALP: Mary Arlene A. Bongosia, MD

PANORS: Norberto V. Martinez, MD

PAPO: Adonis B. Jurado, MD

PAR: Benjamin S.A. Campomanes, MD

PASS: Keith Romeo A. Aguilera, MD

FINANCE COMMITTEE BLOCK

Elmo R. Lago, MD

Chair

WAYS AND MEANS

Charlotte M. Chiong, MD

Chair

Ruben Emil D. Henson, MD

Manuel E. Villegas, MD

BOOTHS AND EXHIBITS

Mary Aimee S. Singson, MD

Chair

Jenny D. Catignas - Pongco, MD

Mark E. Nocom, MD

Neil B. Regino, MD

LOGISTICS & PROMOTIONS

COMMITTEE BLOCK

REGISTRATION & INVITATIONS

Robert R. Dy, MD

Chair

Danilo D. Deveza Jr., MD

Dominador Enrique E. Gomez, MD

Mary Jane S. Mallillin, MD

Romel D. Mercado, MD

Vangie S. Sumulong, MD

PHYSICAL ARRANGEMENT

Joseph Arnold R. Darvin, MD

Chair

Elmer M. Dela Cruz, MD

Oliver Glenn C. Domingo, MD

Kennard Q. Felix, MD

Aileen DS. Garcia, MD

Patrick Joseph A Prado, MD

Katrina Louise Q. Reyes, MD

Angelo Ian A. Sampelo, MD

Maria Elaine D. Villanueva, MD

DOCUMENTATION & PUBLICITY

Danilo D. Deveza Jr., MD

Chair

Rene Louie C. Gutierrez, MD

Arnelle Y. Quiambao, MD

SOCIAL EVENTS COMMITTEE BLOCK

Rebecca R. Feliciano, MD

Chair

GALA & FELLOWSHIP NIGHT

Cecile C. Capinpin, MD

Arnelle Y. Quiambao, MD

Ma. Cristina B. Viceral, MD

OPENING CEREMONIES

Alberto F. Calderon, MD

Chair

Jaime Anthony A. Arzadon, IV, MD

Leonides P. Cayetano, MD

Maria Elaine D. Villanueva, MD

SPORTS

Peter R. Jarin, MD

Chair

Ramon V. Carmona, Jr., MD

John Rodolfo D. Suan, Jr., MD

SECRETARIAT

Mia Filipina B. Mabuti

Mellissa B. Martinez

Sharon T. Barraquiel

Francisco H. Tutaan


CONFERENCE GUIDELINES

IDENTIFICATION CARDS

Upon registration, an attendee is given an ID

card. This must be worn at all times for

admission to the plenary and symposia

sessions and official social functions.

ID cards are color coded according to the

participants’ wit:

YELLOW Organizing Committee

Secretariat

GREEN Board of Trustee

Chapter President

PBO - HNS Director

PSO - HNS Past President

Senior Member

BLUE Delegate

RED Speaker

ORANGE Day Registrant

PURPLE Sponsor/ Exhibitor

Accompanying Person

Please approach members of the organizing

committee or the secretariat staff for

assistance.

SCIENTIFIC PROGRAM

Please read the delegates’ programme section

to get detailed information on the schedule.

Please be punctual, as sessions will commence

on time. Smoking is strictly prohibited in all

session rooms. Absolute silence is requested

throughout the speakers’ presentations. Please

switch to silent mode all hand held phones.

LUNCH & DINNER SYMPOSIA

Meal stubs will be collected by the waiters

prior to being served. Please do not lose your

stubs.

CONFERENCE SECRETARIAT ROOM

The conference secretariat room is located at

Executive 12 West, Marriott Grand Ballroom.

It will be open on November 30 - December 2,

2015, from 8:00 AM to 5:00 PM.

Convention IDs and

Meal Stubs


VICINITY MAP

MARRIOT GRAND BALLROOM

Newport Boulevard

Newport City Complex

Pasay City, Philippines


FLOOR PLAN

Plenary: Ballrooms A & B

Registration: Foyer (West)

Secretariat: Executive 12 West

Booths & Exhibits: Ballrooms C & D

Speakers’ Viewing Room: Executive 13 West

Ballroom


PRE - CONGRESS CONFERENCES

3RD PAR ENDOSCOPIC SINUS SURGERY COURSE: “MASTERING

THE BASICS” LECTURE & FRESH FROZEN CADAVER DISSECTION November 28 - 29, 2015

The Medical City


PROGRAM AT A GLANCE

5:00 AM - 7:00 AM UAP - PSO-HNS Health Wellness Activity 2015

Sponsored by: United American Pharmaceuticals Inc.

Executive Room 6 & 8 East

Marriott Grand Ballroom

7:30 AM - 5:00 PM R E G I S R A T I O N

9:00 AM - 10:45 AM O P E N I N G C E R E M O N I E S

Keynote Speaker: Hon. Maria Leonor G. Robredo

Ballrooms A & B

10:45 AM - 11:00 AM OPENING OF BOOTHS AND EXHIBITS

11:00 AM - 12:30 PM LUNCH SYMPOSIUM 1


Ballrooms A & B

12:30 PM - 1:30 PM P1: Thyroid Cancer

Ballrooms A & B

1:30 PM - 2:30 PM P2: Computer-Aided Head & Neck Surgery and Updates in the

Management of Laryngeal Cancer

Ballrooms A & B

2:30 AM - 3:00 PM C O F F E E B R E A K

Sponsored by: Natrapharm Inc.

3:00 PM - 4:00 PM S1: Neck Dissection

Ballroom A

S2: NPCA

Ballroom B

4:00 PM - 5:00 PM S3: Raman Spectroscopy

Ballroom A

S4: Sinonasal & Orbital Tumors

Ballroom B

7:00 PM - 8:00 PM DINNER SYMPOSIUM 1


Ballrooms A & B

8:00 - 12:00 MN GALA NIGHT

Sponsored by: PSO - HNS

Ballrooms A & B

DAY 1 (November 30, 2014, Monday)


PROGRAM AT A GLANCE

7:00 AM - 3:00 PM ELECTION OF PSO - HNS BOARD OF TRUSTEES

Executive 10 West

8:00 AM - 9:00 AM Free Paper Presentation 1

Executive 14 East

9:00 AM - 10:00 AM P3: Social Media

Ballrooms A & B

10:00 AM - 10:30 AM CME ACTIVITY

Executive 10 & 11 West

C O F F E E B R E A K

10:30 AM - 11:30 AM P4: Parathyroid & Salivary Gland Tumors

Ballrooms A & B


Sponsored by: Hi - Eisai Pharmaceutical Inc.

Ballrooms A & B

1:30 PM - 2:30 PM S5: Apps & EMR

Ballroom A

S6: New Technologies

Ballroom B

2:30 PM - 3:30 PM S7: Laryngeal Oncology/ Vocology

Ballroom A

S8: Innovations in RPS

Ballroom 2B

3:30 PM - 4:30 PM RESIDENTS’ FORUM: Meet the Experts - Head & Neck

Ballroom B

3:30 PM - 5:30 PM FELLOWS BUSINESS MEETING

Ballroom A

4:30 PM - 5:30 PM PRO - HNS Quiz Bee

Ballroom B

5:30 PM - 7:30 PM PRE - ALUMNI NIGHT COCKTAILS

Sponsored by: Biomedis

House Manila, Remington Hotel

7:30 PM - 8:00 PM VERTIGO FORUM

The Bellevue Manila, Alabang, Muntinlupa

8:00 PM—12:00 AM ALUMNI NIGHT

DAY 2 (December 1, 2015, Tuesday)


PROGRAM AT A GLANCE

8:00 AM - 9:00 AM PJO - HNS Workshop



Executive 14 East

9:00 AM - 10:00 AM P5: Oral Cavity Cancer

Ballrooms A & B

10:00 AM - 10:30 AM C O F F E E B R E A K

10:00 AM - 11:00 AM Poster Session Contest on Surgical Innovation & Instrumentation

Executive 14 East

10:30 AM - 11:30 AM P6: Prognostication in Head & Neck Cancer

Ballrooms A & B


Sponsored by: Sandoz Philippines

Ballrooms A & B

1:30 PM - 2:30 PM S9: Computer Aided Surgery

Ballroom A

S10: Pediatric ORL: JNA & Vascular

Tumors

Ballroom B

2:30 PM - 3:30 PM S11: Sleep

Ballroom A

S12: Current Concepts: COM &

Skull Base Surgery

Ballroom B

3:30 PM - 4:30 PM S13: Plastic Surgery in ORL

Ballroom A

S14: Audiology

Ballroom B

6:00 PM - 7:00 PM DINNER SYMPOSIUM 2

Sponsored by: A. Menarini Philippines Inc.

Ballrooms A & B

7:00 PM - 8:00 PM C L O S I N G C E R E M O N I E S

Ballrooms A & B

8:00 PM - 12:00 MN FELLOWSHIP NIGHT


Ballrooms A & B

DAY 3 (December 2, 2015, Wednesday)


PROGRAM OF ACTIVITIES

5:00 AM - 7:00 AM UAP - PSO-HNS Health Wellness Activity 2015


Executive Rooms 6 & 8 East

7:30 AM - 5:00 PM R E G I S R A T I O N

Sponsored by: UniCARE - United Laboratories, Inc.

9:00 AM - 10:45 AM O P E N I N G C E R E M O N I E S

Keynote Speaker: Hon. Maria Leonor Gerona Robredo

Ballrooms A & B

10:45 AM - 11:00 AM OPENING OF BOOTHS AND EXHIBITS

11:00 AM - 12:30 PM LUNCH SYMPOSIUM 1:

The Use of Oral Systemic Corticosteroid in ENT Practice

Gil M. Vicente, M.D. (Philippines)

Ruzanne M. Caro, M.D. (Philippines)


Ballrooms A & B

12:30 PM - 1:30 PM PLENARY 1: Thyroid Cancer

Ballrooms A & B

Chair: Teresa Luisa Gloria-Cruz, M.D.

Co-chair: Patrick Pardo, M.D.

Thyroid Cancer - Triumph Over Butchery

Ashok R. Shaha, M.D., FACS (USA)

1:30 PM - 2:30 PM PLENARY 2: Computer-Aided Head & Neck Surgery and Updates in the

Management of Laryngeal Cancer

Ballrooms A & B

Chair: Josefino G. Hernandez, M.D.

Co - Chair: Lei-Joan S. Vital, M.D.

Computer - Aided Surgery Around the Head: 18 Years of Experience

Prof. Marco Caversaccio, M.D. (Switzerland)

Updates in the Management of Laryngeal Cancer

Alfredo Q.Y. Pontejos Jr., M.D. (Philippines)

DAY 1 NOVEMBER 30, 2015 MONDAY



2:30 AM - 3:00 PM C O F F E E B R E A K

Sponsored by: Natrapharm Inc.

3:00 PM - 4:00 PM SYMPOSIUM 1: Neck Dissection

Ballroom A

Chair: Virgilio R. De Gracia, M.D.

Co-chair: Manuel E. Villegas, M.D.

Updates in the Classification of Neck Dissection

Alfredo Q.Y. Pontejos, M.D. (Philippines)

The Role of Elective Dissection in Head & Neck Cancer


The Role of Therapeutic Neck Dissection in Head & Neck Cancer

Dominiek Monserez, M.D. (Netherlands)

SYMPOSIUM 2: NPCA

Ballroom B

Chair: Robie V. Zantua, M.D.

Co-chair: John V. Silva, M.D.

Salvage Nasopharyngectomy for NPCA from Open to Endoscopic

Sheng - Po Hao, M.D., FACS, FICS (Taiwan)

All That is New in Radiation Treatment of NPCA

Johanna Patricia A Cañal, M.D., MHA (Philippines)

NPCA: Updates on Management with Chemotherapy

Marlinda Adham, M.D. (Indonesia)

4:00 PM - 5:00 PM SYMPOSIUM 3: Raman Spectroscopy & Phytotherapy

Ballroom A

Chair: Emmanuel L. Ibay, M.D.

Co-chair: Mario Adrian M. Zafra, M.D.

Resection Margins in Oral Cavity Tumor & Raman Spectroscopy

Jose Angelito U. Hardillo, M.D., PhD (Netherlands)

Phytotherapy in Head & Neck Cancer

Prof. Lars Eric Pontus Stierna, M.D., PhD (Sweden)



4:00 PM - 5:00 PM SYMPOSIUM 4: Sinonasal & Orbital Tumors

Ballroom B

Chair: Rhodora A. del Rosario-Ocampo, M.D.

Co-chair: Cherry Gay G. Gatchalian, M.D.

Management of Inverted Papilloma in the New Millenium


Conquering Conundrums in Orbital Tumors & Pseudotumors

Ma. Donna D. Santiago, M.D., MBA (Philippines)

7:00 PM - 8:00 PM DINNER SYMPOSIUM 1:

Cefuroxime: Across-the-Board Option in ORL - HNS Surgery

Teresa Luisa Gloria - Cruz, M.D. (Philippines)


Ballrooms A & B

8:00 - 12:00 MN GALA NIGHT


Ballrooms A & B

DAY 2 DECEMBER 1, 2015 TUESDAY

7:00 AM - 3:00 PM ELECTION OF PSO - HNS BOARD OF TRUSTEES

Executive 10 West


Executive 14 East

Moderator: Samantha S Castaneda, M..D.



9:00 AM - 10:00 AM PLENARY 3: Social Media

Ballrooms A & B

Chair: Philip B. Fullante, M.D.

Co-chair: Rodante A. Roldan, M.D.

Social Media & the Health Professionals

Iris Thiele Isip Tan, M.D., MSc (Philippines)

To Click or Not to Click: Social Media & the M.D.

Ivy D. Patdu - Calaquian, M.D., J.D. (Philippines)

10:00 AM - 10:30 AM CME ACTIVITY

Leading the Way in the Management of ENT Diseases:

Through the Years

Josefino Hernandez, M.D. (Philippines)

C O F F E E B R E A K

10:30 AM - 11:30 AM PLENARY 4: Parathyroid & Salivary Gland Tumors

Ballrooms A & B

Chair: Jacob S. Matubis, M.D.

Co-chair: Daniel M. Alonzo, M.D.

Surgical Management of Hyperparathyroidism


Evaluation & Management of Parotid Tumors



Simplifying LPR Diagnosis & Assessment of Therapy -

The Filipino Reflux Symptom Index

Jose Florencio F. Lapeña Jr., M.D.

Sponsored by: Hi - Eisai Pharmaceutical Inc.

Ballrooms A & B

1:30 PM - 2:30 PM SYMPOSIUM 5: Apps & ELECTRONIC MEDICAL RECORDS

Ballroom A

Chair: Rene S. Tuazon, M.D.

Co-chair: Geraldine L. Luna, M.D.

Mobile Applications for the #ConnectedENT

Philip B. Fullante, M.D. (Philippines)

EMR in the Philippines: Current State, Benefits & Challenges

Michael Hussin B. Muin, M.D. (Philippines)

Computerizing the Practice & Leveraging the Information

Jerry Rapes (Philippines)

Willex Perez (Philippines)



1:30 PM - 2:30 PM SYMPOSIUM 6: New Technologies

Ballroom B

Chair: Joel A. Romualdez, M.D.

Co-chair: Franco Louie Abes, M.D.

Self Developed Robot for Cochlea Implantation: Reality or Future?


Possible Indications for Computer Aided Surgery on the Lateral Skull

Base


A New & Complete Tool for ENT Surgeons in Diagnosing OSAS

Magne Tvinnereim, M.D., PhD (Norway)

2:30 PM - 3:30 PM SYMPOSIUM 7: Laryngeal Oncology & Vocology

Ballroom A

Chair: Frederick Y. Hawson, M.D.

Co-chair: Fortuna Corazon Aberin-Roldan, M.D.

LASER Surgery for Early Stage Laryngeal Cancer

William L. Lim, M.D. (Philippines)

LASER Surgery for Management of Recurrent Laryngeal Cancer

Prof. Dr. Robert Baatenburg De Jong, (Netherlands)

Voice Care Essentials: Portable Voice Amplifier & Voice Aerobics

Mary Arlene A. Bongosia, .M.D. (Philippines)

SYMPOSIUM 8: Innovations in Rhinopharyngology

Ballroom B

Chair: Josefino G. Hernandez, M.D.

Co-chair: Ma. Lourdes B. Enecilla, M.D.

Hospital Information System for the Future: SNUBH Way

Chae-Seo Rhee, M.D. (South Korea)

Sublingual Immunotheraphy in Korea: Perspective from Rhinologists


Innovations in the Diagnosis & Management of OSAS




3:30 PM - 4:30 PM RESIDENTS FORUM: Meet the Experts - Head & Neck

Ballroom B

Moderators: Kirt Areis Delovino , M.D. & Jan Warren A Holgado, M.D.

Panelists:


Prof. Dr. Robert Baatenburg De Jong (Netherlands)



3:30 PM - 5:30 PM FELLOWS’ BUSINESS MEETING

Ballroom A

4:30 PM - 5:30 PM PRO - HNS QUIZ BEE

Ballroom B

5:30 PM - 7:30 PM PRE - ALUMNI NIGHT COCKTAILS

Sponsored by: Biomedis

House Manila, Remington Hotel

7:30 PM - 8:00 PM VERTIGO FORUM

The Bellevue Manila, Alabang, Muntilupa

8:00 PM—12:00 MN ALUMNI NIGHT

DAY 3 DECEMBER 2, 2015 WEDNESDAY

8:00 AM - 9:00 AM PJO - HNS WORKSHOP: Electronic Manuscript Submission for

Publication in the Philippine Journal of Otolaryngology-Head & Neck

Surgery: How to Submit a Manuscript and Hurdle the Peer Review

Jose Florencio F. Lapeña Jr., M.D., MA (Philippines)



Executive 14 East


9:00 AM - 10:00 AM PLENARY 5: Oral Cavity Cancer

Ballrooms A & B

Chair: Mamerto G. Almelor, Jr., M.D.

Co-chair: Armando M. Chiong, Jr., M.D.

Pre - Treatment Assessment in Oral Cancer


Contemporary Surgical Management of Oral Cancer




10:00 AM - 10:30 AM C O F F E E B R E A K

10:00 AM - 11:00 AM Poster Session Contest on Surgical Innovation & Instrumentation

Executive 14 East


10:30 AM - 11:30 AM PLENARY 6: Prognostication in Head & Neck Cancer

Ballrooms A & B

Chair: Daniel M. Alonzo, M.D.

Co-chair: Arsenio Claro A. Cabungcal, M.D.

Model for Prognostication in Head & Neck Cancer


Prognostication of HPV(+) & Response to Radiotherapy for Head &

Neck Cancer



The Art of Healing the Nose. The Science of Breathing in Harmony

Gil M. Vicente, M.D. (Philippines)

Sponsored by: Sandoz Philippines

Ballrooms A & B

1:30 PM - 2:30 PM SYMPOSIUM 9: Computer Aided Surgery

Ballroom A

Chair: Jehan Grace B. Maglaya, M.D.

Co-chair: Joselito F. David, M.D.

Improving the Outcomes with Preoperative 3D Planning & Computer

Aided Surgery in Craniomaxillofacial Reconstruction

Francis V. Roasa, M.D. (Philippines)

Improving Outcomes with Computer Planning in Intra Operative

Navigation in Craniomaxillofacial Surgery

Ferdinand G. Pamintuan, M.D. (Philippines)



1:30 PM - 2:30 PM SYMPOSIUM 10: Pediatric ORL: JNA and Vascular Tumors

Ballroom B

Chair: Adonis B. Jurado, M.D.

Co-chair: Antonio H. Chua, M.D.

Surgical Approaches to Juvenile Nasopharyngeal Angiofibroma

Lyra V. Veloro, M.D. (Philippines)

Treatment Options for Pediatric Vascular Tumors of the Head & Neck

Cecilia Gretchen S. Navarro-Locsin, M.D. (Philippines)

2:30 PM - 3:30 PM SYMPOSIUM 11: Sleep

Ballroom A

Chair: Romulus Roberto Peter A. Instrella, M.D.

Co-chair: Maria Patricia Ann T. Puno, M.D.

Wearable for Sleep Apnea

Keith Romeo A. Aguilera, M.D. (Philippines)

Effect of Head & Neck Cancer on Sleep

Jonalyn Chris T. Ang, M.D. (Philippines)

SYMPOSIUM 12: Current Concepts: COM & Skull Base Surgery

Ballroom B

Chair: Erasmo Gonzalo D.V. Llanes, M.D.

Co-chair: Joanne Sebastian M. De Ramos, M.D.

NHSRC Registry: An IT Model

Ryan Julius Bañez, M.D. (Philippines)

Telemetry Unleashed: A Singaporean Experience with Remote

Assistants in Intraoperative Neural Response Telemetry

Barrie Yau Boon Tan, M.D. (Singapore)

Cochlear Implants in Single-Sided Deafness for Sudden Sensorineural

Hearing Loss: Early Findings of a Singaporean Prospective Study




3:30 PM - 4:30 PM SYMPOSIUM 13: Plastic Surgery in ORL

Ballroom A

Chair: Cesar V. Villafuerte, M.D.

Co-chair: Jaime Anthony A. Arzadon IV, M.D.

Cutaneous Surgery

John M. Hodges, M.D., FACS (USA)

Creating a Functional Nose with Rhinoplasty


Facial Plastic Surgery Overview


3:30 PM - 4:30 PM SYMPOSIUM 14: Audiology

Ballroom B

Chair: Howard M. Enriquez, M.D.

Co-chair: Diosdado C. Uy, M.D.

Stimulus Considerations for ABR & ASSR Recording

Andre Lodwig, M.D. (Germany)

Impact of Stimulus Selection on ABR & ASSR Performance

Mr. Russell Higgs (United Kingdom)

6:00 PM - 7:00 PM DINNER SYMPOSIUM 2:

Bilastine: The Philippine Experience

Josefino G. Hernandez, M.D. (Philippines)

Margaret C. Lim - Jurado, M.D. (Philippines)

Sponsored by: A. Menarini Philippines Inc.

Ballrooms A & B

7:00 PM - 8:00 PM C L O S I N G C E R E M O N I E S

Ballrooms A & B

8:00 PM - 12:00 MN FELLOWSHIP NIGHT


Ballrooms A & B


ABSTRACTS (PLENARY)

PLENARY 1: Thyroid Cancer November 30, 2015 (12:30 - 1:30 PM)

THYROID CANCER - TRIUMPH OVER BUTCHERY


There is a rapid of increase of thyroid cancer all over the world. The majority of these are

micro carcinomas on incidental findings. Several nuances have been made in the diagnostic

evaluation, with molecular markers. The debate about extent of thyroidectomy has been essentially

resolved up to 4cm as lobectomy, the choice of treatment. There continues to be considerable

debate regarding the central compartment nodal dissection, however the general consensus is to

consider selective nodal dissection with suspicious nodal involvement. The radioactive iodine is

rarely used in low risk thyroid cancer patients. The decisions about extent of thyroidectomy and

adjuvant treatment are based now on the risk group analysis. The role of external radiation

therapy is fairly well defined for better control of the local disease in the thyroid area.

Enormous progress has been made in medullary thyroid carcinoma with RET mutation and

prophylactic total thyroidectomy. Anaplastic thyroid carcinoma continues to be difficult problem

with high mortality.


ABSTRACTS (PLENARY)

PLENARY 2: Computer Aided Head & Neck Surgery & Updates in the Management of

Laryngeal Cancer November 30, 2015 (1:30 - 2:30 PM)

COMPUTER AIDED SURGERY AROUND THE HEAD: 18 YEARS OF EXPERIENCE


Microscopic or endoscopic skull base surgery is technically demanding and its outcome has

a great impact on a patient’s quality of life. Our research group in Bern is aimed at developing and

evaluating enabling navigation surgery tools for simulation, planning, training, education and

performance since 18 years. Other commercial products have been integrated. Clinically applied

technological research with patient series for anterior and lateral skull base procedures were

treated between 1997-2015. Optical tracking technology was used for positional sensing of

instruments. Specific designed dynamic reference base with different registration techniques using

e.g. a fine needle pointer or ultrasound, enables the surgeon to work with a target error of < 1mm.

An automatic registration assessment method, which provides the user a color-coded fused

representation of CT and MR images, indicates to the surgeon the location and extent of

registration accuracy. Additionally, guidance information (augmented reality) from multimodal

datasets (CT, PET-CT, MRI, Angiography) can be overlayed directly onto the surgical microscope

view or the endoscope. A virtual simulator as a training tool could allow in endonasal and

otological skull base surgery the understanding and preoperative practice with real-patient data in

a residency program. An improved quality of surgical outcome and satisfaction for the surgeon

was identified compared to our control group without navigation and compared to the literature.

Acknowledgments: supported by the Swiss National Science Foundation www.co-me.ch,

and ISTB www.istb.unibe.ch Prof. L.P. Nolte. www.hno.insel.ch.


ABSTRACTS (PLENARY)

PLENARY 2: Computer Aided Head & Neck Surgery & Updates in the Management of

Laryngeal Cancer November 30, 2015 (1:30 - 2:30 PM)

UPDATES IN THE MANAGEMENT OF LARYNGEAL CANCER


Modern day laryngeal cancer surgery is built upon the work of a long succession of

predecessors, from the time of Bilroth in 1873 (total laryngectomy) to Joseph Ogura

(hemilaryngectomy) in 1955 to Jako and Kleinsasser in 1966 (CO2 LASER resection).

Aside from surgery, other modalities developed particularly radiotherapy, chemotherapy,

and targeted therapy. The incidence of laryngeal cancer in the Asia-Pacific ranges from 0.6 to 6.3

per 100,000. Therefore, it carries a heavy health burden for the region.

Each country follows certain management protocols, however, the most popular would still

be the NCCN guidelines. Total laryngectomy remains to be the gold standard in the management

of laryngeal cancers specifically in stage IV cancer. In the Philippines, we follow certain guidelines.

For T1/T2 cases, radiotherapy or open/endoscopic surgery are the options. For T3 cases, options

are conservation surgery or concurrent chemotherapy and radiotherapy.

With the publication of the VA trial in 1991, there was a trend towards non-surgical

conservation management, particularly chemoradiation, and this developed to some confusion

resulting in a decrease in the overall survival of laryngeal cancer patients as shown in the SEER

reports.

There is a need therefore to come up with further researches comparing non-surgical

conservation management versus surgical management in treatment of laryngeal cancer.

Of course, personalized care is the way to go in managing our laryngeal cancer patients.

Treatment should be individualized for each patient with regards to overall patient condition,

stage of the disease, and numerous social and cultural considerations (Drago Prgomet, 2012). And

as Dr. Javier Gavilan would say, “there are no treatment of choice but rather choices of treatment.”


ABSTRACTS (PLENARY)

PLENARY 3: Social Media December 1, 2015 (9:00 - 10:00 AM)

SOCIAL MEDIA & THE HEALTH PROFESSIONALS

Iris Thiele Isip Tan, M.D., MSc (Philippines)

TO CLICK OR NOT TO CLICK: SOCIAL MEDIA AND THE M.D.

Ivy D. Patdu-Calaquian, M.D., JD (Philippines)

Social Media is the new avenue for sharing of information. Through social media, one can

reach a global community. It has been an invaluable tool for health education and social

networking. In a world where information is power, social media occupies a unique position. The

challenge has been to use the power afforded by social media responsibly, and to define the line

between use and abuse. While there are existing laws which could serve as anchor for complaints

of those aggrieved by abuse of social media, use of social media has apparently been unregulated

because of its very nature. With one click, an opinion can become fact, and an unverified fact

becomes truth. Its extensive use has blurred the lines between professional and personal lives. The

use of social media also raises concerns for the patient’s right to privacy and the extent by which it

should be protected. In the end, medical professionals should understand that the benefits of social

media comes with an obligation. Use of social media requires a personal commitment to uphold

the ethical standards required of the medical professional, upon which patient trust is built.


ABSTRACTS (PLENARY)

PLENARY 4: Parathyroid & Salivary Gland Tumors December 1, 2015 (10:30 - 11:30 AM)

SURGICAL MANAGEMENT OF HYPERPARATHYROIDISM


The incidence of parathyroid surgery has increased considerably. Hyperparathyroidism is

the 2nd most common cause of primary hyperparathyroidism. The NIH has developed guidelines

for considering surgery in asymptomatic mild hypercalcemia such as age, bone density score, etc.

Clearly the patient’s general well being improves considerably after parathyroidectomy. However,

certain patients with mild hypercalcemia can be easily treated with medication and close follow

up. There is considerable interest now in localization leading to focal surgical exploration. The best

studies for localization are Sestamibi scan, ultrasound and 4D CT scan. If the glands cannot be

identified, bilateral surgical exploration would be most appropriate.

Recently, there is a considerable interest in intraoperative quick PTH. If the PTH drops by

more than 50% and within normal limits the surgical success is excellent. Some centers use gamma

probe for intraoperative parathyroid localization with excellent surgical success, however recently

they have reverted to bilateral surgical exploration. Occasionally, a parathyroid gland may be

found intimately adherent to the thyroid gland at which time due to consideration should be given

for thyroid lobectomy as this may turn out eventually to be parathyroid cancer. Preoperative

ultrasound will also identify any thyroid abnormality in these patients and appropriate

intervention may be undertaken for thyroid nodules. The success of parathyroid surgery exceeds

95%, however the persistent hyperparathyroidism requires in detail evaluation of the diagnosis,

best localization studies and re-exploration. The majority of the hidden parathyroid glands are

behind the esophagus, in the superior mediastinum or undescended parathyroid glands. The

intraoperative PTH has revolutionized the success of parathyroid surgery.


ABSTRACTS (PLENARY)

PLENARY 4: Parathyroid & Salivary Gland Tumors December 1, 2015 (10:30 - 11:30 AM)

EVALUATION AND MANAGEMENT OF PAROTID TUMORS


The majority of the parotid tumors are benign. The most common benign tumor is

pleomorphic adenoma and the most common malignant tumor is mucoepidermoid carcinoma and

adenoid cystic carcinoma. The common presentation of the salivary gland tumors is a lump in the

parotid region.

Occasionally, patients may present in advance stage with lymph node metastasis or facial

palsy. The diagnostic evaluation, appropriate imaging studies which may include CT scan or MRI.

Recently, there is an interest in ultrasound and ultrasound guided needle biopsy. Needle biopsy is

an important investigation to rule in salivary gland pathology versus non-salivary pathology.

However, it fails to distinguish accurately between benign or malignant tumor. The majority of the

patients with salivary gland tumors will require surgical intervention. Certain benign conditions

such as pleomorphic adenoma or Warthin’s tumor may be observed, specially in patients with

co-morbidities.

The most appropriate surgical intervention includes superficial parotidectomy. There

appears to be considerable interest in partial parotidectomy with identification and preservation of

the lower division of the facial nerve, The entire parotid surgery revolves around injury to the

facial nerve. The operating surgeon should be familiar with the anatomy and recognition of the

facial nerve appears to be directly involved by the tumor it would require appropriate sacrifice and

reconstruction. The postoperative adjuvant radiation therapy is used for high risk parotid tumors

where stage is more important than grade of the tumor. There is some interest in use of neutron

therapy as a primary treatment in patients with advance salivary gland tumors. Occasionally, the

patient may present with minor salivary gland tumors involving the sinuses, base of the tongue or

upper aerodigestive tract.


ABSTRACTS (PLENARY)

PLENARY 5: Oral Cavity Cancer December 2, 2015 (9:00 - 10:00 AM)

PRE-TREATMENT ASSESSMENT IN ORAL CAVITY

Prof. Dr. Robert J. Baatenburg De Jong (Netherlands)

CONTEMPORARY SURGICAL MANAGEMENT OF ORAL CANCER

Sheng-Po Hao, M.D., FACS, FICS (Taiwan)

Oral cavity cancer is a global issue, especially in the Asia-Oceania regions. The contemporary

management of oral cancer can be focused on the following principles:

1. Management of Oral Potential Malignant Disorders (OPMD): prevention, screening,

diagnosis and malignant transformation detection and chemoprevention.

2. Surgical principals: extend of resection, functional preservation of surgical approaches,

appropriate reconstruction

3. Paradigm shift in surgical approach, from open to endoscopic

4. Neck dissections: elective versus therapeutic

5. Clinicopathological parameters, prognosticators

6. Adjuvant combined chemoradiation therapy


ABSTRACTS (PLENARY)

PLENARY 6: Prognostication in Head & Neck Cancer December 2, 2015 (10:30 - 11:30 AM)

MODEL FOR PROGNOSTICATION IN HEAD & NECK CANCER


PROGNOSTICATION OF HPV(+) & RESPONSE TO RADIOTHERAPY FOR HEAD &

NECK CANCER


Human papillomavirus (HPV) associated head and neck squamous cell carcinoma

(HNSCC), particularly oropharyngeal squamous cell carcinoma (OPSCC), are characterized by a

significant survival advantage over their HPV-negative counterparts. Although the reasons behind

this are still not fully elucidated, it is widely accepted that these tumors have a higher response to

ionizing radiation that might explain their favourable outcomes. In Rotterdam, oropharyngeal

carcinomas are treated mainly with locoregional radiotherapy, 46 GY using IMRT, followed by a

local boost using cyberknife or brachytherapy and neck dissection for clinically N+ cases. In a

recent review of 92 N+ cases treated between 1999-2012, 70% were positive for p16 (p16+). 34% had

a full downstaging of N status (pN0) after 46 Gy using IMRT while another 20% had a partial

downstaging of N status. Although not significant, p16+ tumors have an odds ratio of 3.26 in

achieving full downstaging of N status after IMRT.

Tumors with full regional control (pN0) after IMRT have significantly better survival. P16+

tumors had significantly better overall 5 year and disease free survival than p16– tumors.


ABSTRACTS (SYMPOSIUM)

SYMPOSIUM 1: Neck Dissection Ballroom A November 30, 2015 (3:00 - 4:00 PM)

UPDATES IN THE CLASSIFICATION OF NECK DISSECTION


In the 1800’s, Kocher, Billroth, von Lagenbeck, and von Volkmann described surgical

lymphadenectomy. In 1888, Jawdynski described in detail the first successful radical en bloc

resection of metastatic mass in the neck. In 1906, Dr. George W. Crile presented the concept of

radical neck dissection. And in 1953, Dr. Hayes Martin published articles on radical surgery of the

head and neck and described en bloc resections. Functional neck dissection was introduced by Dr.

Oswaldo Suarez in the 1960’s then Drs. Ettore Bocca, Cesar Gavilan, and Richard Jesse propagated

functional neck dissection from which selective neck dissection evolved.

Neck dissection is performed if there are obvious neck nodes and if there is a 20% chance of

neck node metastasis in head and neck cancers.

For us to understand the different kinds of neck dissection, we have to know the different

levels of the lymphatic system of the neck. American Head & Neck Society introduced in 2001 a

classification for neck dissection based on the levels of cervical lymph nodes removed. The

conceptual guidelines for neck dissection included radical neck dissection, modified radical neck

dissection, selective neck dissection, and extended radical neck dissection. In 2008, AHNS

published an update on neck dissection classification in which level VII was added to the lymph

node groups.

Problems arise when certain non-lymphatic tissues are included in the removal of lymph

nodes as in a neck dissection wherein levels I, II, III are removed plus the SCM and IJV. How will

you classify this based on the 2008 classification? So the Japanese Society of Clinical Oncology tried

to develop a classification system by which this could be addressed. However, it was even more

confusing.

In 2010, Ferlito et al proposed a new and simpler classification of neck dissection which will

be discussed in the presentation.




THE ROLE OF ELECTIVE NECK DISSECTION IN HEAD & NECK CANCER


The overall incidence of metastatic disease in N0 is approximately 20%. The most

important prognostic factor in the head and neck cancer is presence of metastatic disease which

reduces the overall survival by 50%. The patient’s who are likely to develop nodal disease are with

larger tumors, depth of infiltration, poorly differentiated and location of the tumor. The incidence

of nodal disease is approximately 25% in T1 cancer while it goes between 40-60% in T2 and T3

tongue cancer. The patterns of nodal metastasis are well defined in head and neck cancer. The

majority of the oral cavity cancer generally metastasize to levels I, II and III and supraomohyoid

neck dissection can be easily performed. The question always comes about surgery versus

radiation therapy. Radiation therapy is equally good and effective treatment in N0 neck however

the recent studies from Tata Memorial hospital and from Brazilian groups have shown that

performing a neck dissection in N0 state is much better that radiation itself. Once the nodal

disease is identified certain prognostic features need to be studied such as number of nodes,

extranodal extension, and the size of the tumor. Based on which further adjuvant treatment such

as postoperative radiation therapy needs to be considered. Certain complications of node

dissection specifically related to selective nodal dissection need to be recognized such as shoulder

weakness and rarely injury to the lower division of the facial nerve (marginal mandibular nerve).




THE ROLE OF THERAPEUTIC NECK DISSECTION IN HEAD & NECK CANCER


Head and neck malignancies frequently metastasize to the cervical lymph nodes, an

occurrence that has a markedly negative impact on prognosis. Treatment of the cervical neck

nodes, is mostly part of the treatment strategy, especially in advanced stages. When the primary

tumor is surgically treated, an ipsilateral or bilateral neck dissection is mostly warranted. The

extent of the therapeutic neck dissection is controversial. Even a modified radical neck dissection

is associated with important morbidity, which can be reduced by excluding some levels from the

resection. Depending on the nature and location of the primary tumor and the N-stage reducing

the extent of the neck dissection without hampering the prognosis can be considered.

Treatment of the neck after definitive radiotherapy, either alone or in combination with

chemotherapy, is even more complex. Traditionally, up to 50% of node positive patients treated

with radiotherapy alone had persistent nodal disease on pathology, which provided the rationale

for a planned neck dissection following definitive radiotherapy. As a result half of the patients

were affected by unnecessary morbidity and complications. Patients with a high risk on residual

nodal disease could benefit of an upfront neck dissection, taken in consideration that treatment of

the primary tumor is delayed. Improvement of RT techniques and the use of chemo radiotherapy

advances in post-treatment restaging and the increase of HPV-related (oropharyngeal) cancers,

decreased the risk of isolated nodal failure significantly. Nowadays observation is preferred over

surgery in the absence of evidence for residual nodal disease or an increased risk of recurrence.

When regional salvage surgery is necessary its extent should be tailored to the residual nodal

disease and the neck levels involved.



SYMPOSIUM 2: NPCA Ballroom B November 30, 2015 (3:00 - 4:00 PM)

SALVAGE NASOPHARYNGECTOMY FOR rNPCA FROM OPEN TO ENDOSCOPIC

Sheng-Po Hao, M.D., FACS, FICS (Taiwan)

Nasopharyngeal carcinoma (NPC) is a common cancer among the Chinese people. NPC is a

squamous cell carcinoma which originates from the epithelial lining of the nasopharynx. Currently

available therapeutic modalities for NPC are radiation therapy (RT), chemotherapy, or a

combination of both. NPC is highly radiosensitive and patients presenting with limited stage

cancer have a high possibility for cure after RT. Concurrent cisplatin based chemo-radiotherapy

with or without neo-adjuvant chemotherapy is currently the standard treatment for patients with

advanced locoregional disease. Though NPC is usually a radiosensitive tumor, some do recur after

RT. Local failure, either persistence or recurrence, in the nasopharynx, occurs in 10% to 30% of

patients with NPC after initial RT.

Salvage nasopharyngectomy has been the mainstay of treatment after RT failure. Surgical

access to the nasopharynx has been a challenge to head and neck surgeons for years. Various

surgical approaches to the nasopharynx have been developed, such as the transpalatal,

transmaxillary, midline mandibulotomy, transpterygoid, facial translocation, and infratemporal

fossa approaches. However, in recent years, there is a paradigm shift for nasopharyngectomy, that

is from open to endoscopic. Minimally invasive endoscopic nasopharyngectomy has been reported

to be a feasible treatment of a small mucosal recurrence. The indication of endoscopic

nasopharyngectomy for rNPC includes lesions of the central roof or floor with minimal lateral

extension. With the aid of navigation, endoscopic nasopharyngectomy can also be a good surgical

intervention in rNPC cases even with skull base bone involvement.



SYMPOSIUM 2: NPCA Ballroom B November 30, 2015 (3:00 - 4:00 PM)

ALL THAT IS NEW IN RADIATION TREATMENT OF NASOPHARYNGEAL

CARCINOMAS

Johanna Patricia A. Cañal, M.D., MHA (Philippines)

This short talk discusses the technology available for radiotherapy of nasopharyngeal

carcinomas and head and neck tumors today, both abroad and in the Philippines. It includes

advances in both imaging, which is the basis of treatment, and treatment delivery, the op-

erative principle being precision in both dose and target.

NPCA: UPDATES ON MANAGEMENT WITH CHEMOTHERAPY Marlinda Adham, M.D. (Indonesia)

Nasopharyngeal carcinoma (NPC) is endemic in Southern China and Southeast Asia. NPC

is a highly radiosensitive tumor that radiotherapy is the mainstay of treatment with an overall 5-

year survival rate of 40~70%. Although early-stage NPC is highly radiocurable, the treatment

results of locoregionally advanced NPC have been disappointing because of local recurrence and

distant metastases. Several prospective randomized trials and meta-analyses have demonstrated

that concurrent chemoradiotherapy (CCRT) with or without adjuvant chemotherapy is superior to

RT alone in the treatment of locoregionally advanced NPC. The benefit of concurrent

chemoradiotherapy in treating locoregionally advanced NPC is welll established with long-term

survival rates remarkably being improved to 60-70%, but this approach gave a high rate of acute

radiation therapyinduced toxicity and late systemic recurrence. Recent advances in molecular

biology have provided a detailed understanding of the molecular events in carcinogenesis and

may now offer new approaches to the treatment of NPC. Targeted therapies remain a major area of

interest and EGFR has long been hypothesized to be a strategic target in the development of novel

therapies for the treatment of cancer. This overexpression correlates with a poor clinical outcome

in a number of malignancies. Therefore, blockade of EGFR activity would interrupt EGFR-

mediated signal transduction pathways and result in suppression of tumor growth.



SYMPOSIUM 3: Raman Spectroscopy & Phytotherapy Ballroom A November 30, 2015 (4:00 - 5:00 PM)

RESECTION MARGINS IN ORAL CAVITY TUMOR AND RAMAN SPECTROSCOPY


Most oral cancers arise from the epithelium of the mucosal surfaces and are referred to as

oral cavity squamous cell carcinoma (OCSCC). Despite advances in treatment modalities (surgery,

radiotherapy, chemotherapy), survival has not shown significant improvement over the last

decades. Surgery is the mainstay of treatment for OCSCC with adequate tumor resection margins

and preservation of function as the main goals. Adequate resection margins are crucial for disease

control and survival. Although patients with inadequate tumor resection can receive adjuvant

treatment (chemo and or radiation), such treatment can significantly add to the morbidity of

surgery. Recently we reported that adequate resection margins are achieved in only 15% of cases

owing to the complex anatomy of the oral cavity and the difficulty of relying on visual inspection

and palpation by the surgeon, to warrant an adequate resection. Even frozen section procedure, a

time consuming and labor intensive technique, does little to improve the situation as it only allows

inspection of a small portion of the resection margin which may not be representative of all the

margins.

In this symposium, we will discuss the technique of “specimen driven” intraoperative

assessment of resected tissues, our experience with this technique, its merits and limitations in oral

cavity cancer surgery. Finally, we will present Raman spectroscopy, an objective, fast, and less

costly technique which is suitable for a real-time assessment of resection margins.

PHYTOTHERAPY FOR HEAD & NECK CANCER

Prof. Lars Eric Pontus Stierna, M.D., PhD (Sweden)



SYMPOSIUM 4: Sinonasal & Orbital Tumors Ballroom B November 30, 2015 (4:00 - 5:00 PM)

MANAGEMENT OF INVERTED PAPILLOMA IN THE NEW MILLENNIUM


Since the first description of inverting papilloma by Ward in 1865, the tendency towards

local destruction, risk of recurrence and the potential malignant transformation into squamous cell

carcinoma has been constantly emphasized. Sinonasal inverted papilloma (IP) is a neoplasm from

a single progenitor cell originating of the Schneiderian membrane. Human papilloma virus (HPV)

is currently thought to be the leading cofactor in the pathogenesis of IP as an early event in the

multistep tumorigenesis process. The diagnosis is based on clinical suspicion, complemented with

CT and/or MRI, established by histological examination of a biopsy. Many staging systems are

developed since the endoscopic era. The Krouse staging system is most commonly used, although

not designed nor validated as a prognostic tool. Treatment strategy should aim at complete

removal at the first attempt and also effectuate a post-operative situation that allows endoscopic

surveillance. Recurrence rates are influenced by previous surgery, surgical techniques and abilities,

tumorstaging and length of (minimal) follow up. Synchronous squamous cell carcinoma is the

most predominant associated malignancy. There is no consensus on the length and frequency of

follow up. We report on our results of 247 patients treated in a single institution with a minimal

follow up of 24 months. We elaborate on the possible role of SCC-antigen tumor marker during

follow up.

CONQUERING CONUNDRUMS IN ORBITAL TUMORS AND PSEUDOTUMORS

Ma. Donna Santiago, M.D., MBA (Philippines)

This lecture characterizes the clinical and pathological features of patients with

histopathology-confirmed orbital neoplasms and pseudotumors, including neoplasms from

adjacent sinuses that extended into the orbit. The preoperative evaluation, diagnostic imaging and

management will also be discussed.



SYMPOSIUM 5: Apps and EMR Ballroom A December 1, 2015 (1:30 - 2:30 PM)

MOBILE APPLICATIONS FOR THE #ConnectedENT

Philip B. Fullante, M.D. (Philippines)

The year 2015 has seen the tremendous growth of information and communication

technology in everyday use. People and information are now just a screen tap away on our phones

and tablets. Social media and blog sites have conveniently given us access to people and

information that are previously too hard to find. Medical professionals, especially

otorhinolaryngologists, can take advantage of this information explosion in the Internet to improve

health care delivery in clinical practice. We only need to know and use the right tools to become

#connectedENTs. This lecture will present some of the useful mobile apps that even the not-so-tech

-savvy otorhinolaryngologist can use in clinical practice.

ELECTRONIC MEDICAL RECORDS IN THE PHILIPPINES: CURRENT STATE,

BENEFITS AND CHALLENGES

Michael Hussin B. Muin, M.D. (Philippines)

The need for electronic medical records in physician practices is growing. The lecture will

highlight the current state of EMR options in the Philippines, the benefits of using IT-enabled

clinical documentation and the challenges moving forward.

COMPUTERIZING THE PRACTICE AND LEVERAGING THE INFORMATION

Jerry Rapes (Philippines)

Willex Prez (Philippines)

Healthcare delivery is undergoing transformation brought about by sweeping

digital tide. Fundamental to improving patient outcomes, the growing use of electronic

medical records or EMR involves not just finding the right technology but also, promoting

its adoption and use among doctors via usability and managing culture change by

challenging perceived myths and gaining better understanding of the future of healthcare

through use of IT.



SYMPOSIUM 6: New Technologies Ballroom B December 1, 2015 (1:30 - 2:30 PM)

SELF-DEVELOPED ROBOT FOR COCHLEA IMPLANTATION: REALITY OR

FUTURE?

Prof. Marco D. Caversaccio, M.D. (Switzerland)

The aims of minimally invasive cochlear implant surgery are manifold. Different surgical

methods exist such the suprameatal, transcanal or pericanal approach.These methods aim to avoid

wide mastoidectomies while at the same time targeting the round window of the cochlea. In the

last 10 years, patient-specific stereotactic templates, skull-mounted or more conventional

image-guided robotic approaches have been presented by different groups. Robotic minimally

invasive access to the cochlea is gained through a direct cochlear access, which is a small tunnel

drilled from the mastoid surface to the cochlea passing through the facial recess. In addition in a

minimaly invasive access, the preservation of intracochlear structures during and after electrode

array insertion is an important research topic. Since 2008 we are developing in Bern our own robot

for hearing implants together with our Biomedical Engineering center (ARTORG). Tests on human

cadaver heads show high precision of our self-constructed robot and is approved by the Swiss

Ethical Committee for surgery.

Acknowledgments: supported by the Swiss National Science Foundation (Nano Tera

www.nano-tera.ch ), the Hear-EU project FP7 www.hear-eu.eu and Med-EL. Artorg:

www.artorg.unibe.ch Prof. S. Weber




POSSIBLE INDICATIONS FOR COMPUTER AIDED SURGERY ON THE LATERAL

SKULL BASE

Prof. Marco D. Caversaccio, M.D. (Switzerland)

Navigation surgery of the lateral skull base is a rare intervention in daily practice. It’s often

a delicate and difficult minimal invasive intervention in a narrow space. Therefore the orientation

in the temporal bone is often difficult. In case of aural atresia or tumors the normal anatomical

landmarks are often missing rendering the orientation more difficult. Navigation together with

imaging like CT, MR and Angiography support the surgeon in such cases to perform the operation

more accurate and in some cases also in shorter time. With the incorporation of augmented reality,

image-guided PET-CT , actual cone beam CT images surgery will evolve into « information guided

surgery ». Since 18 years we are developing and evaluating enabling navigations surgery tools for

simulation, planning, training, education and performance in Bern. This clinically applied

technological research was complemented by a series of patients.Worldwide, no clear indications

for navigated surgery on the lateral skull base exist.

Acknowledgments: supported by the Swiss National Science Foundation www.co-me.ch

and the Commission of Technology and Innovation in Switzerland. ISTB : Prof. L.P. Nolte

www.istb.unibe.ch; and ARTORG : Prof. S. Weber www.artorg.unibe.ch




A NEW & COMPLETE TOOL FOR ENT SURGEONS IN DIAGNOSING OSAS


New pathological implications as well as documentation of frequent comorbidities has led

to new demands regarding the Diagnosis of OSAS.

Earlier the focus was merely on episodes with increased Respiratory Effort (RE), quantified

by the Apnea-Hypopnea index (AHI).

More recently, it has become evident that episodes without changed airflow- and oxygen

saturation- patterns but with increased RE and simultaneous awakenings (Arousals), represent

pathology as well. This entity is the Respiratory Effort Related Arousals (RERA) and is included in

the terminology: OSA = RERA + AHI = RDI, where RDI (Respiratory Distress Index), represents the

total amount of pathological OSA events.

Hitherto the Arousal detection has demanded PSG with EEG recordings. A newly

innovated physiological parameter replaces these time consuming investigations.

An algorithm using the Gold standard for OSAS diagnosis, the Oesophageal Pressure, combined

with recorded, well-known physiological variables has been established.

A newly developed 0.8 mm thin, soft oesophageal catheter with advanced high-tech micro

pressure-transducers is engaged in giving the complete OSAS diagnosis as well as the Level of

Pharyngeal Obstruction. The latter is mandatory for the ENT – surgeon in the preoperative

evaluation. As RERA is a mild form of OSA, this group is also more prone to successful surgery.

The ApneaGraph Spiro encompasses the innovations and upgrades in one solution. It

comprises a complete, automated, cost-effective and user friendly tool for the ENT – Surgeon when

dealing with OSAS, regarding Diagnosis as well as Treatment Selection.



SYMPOSIUM 7: Laryngeal Oncology & Vocology Ballroom A December 1, 2015 (2:30 - 3:30 PM)

LASER SURGERY FOR EARLY STAGE LARYNGEAL CANCER

William L. Lim, M.D. (Philippines)

LASER SURGERY IN MANAGEMENT OF RECURRENT LARYNGEAL CANCER


VOICE CARE ESSENTIALS: PORTABLE VOICE AMPLIFIER & VOCAL AEROBICS

Mary Arlene A. Bongosia, M.D. (Philippines)

Our advocacy is to promote vocal health. Voice abuse is common among professional

voice users especially teachers. When there is more effort to be heard, there is a need to amplify

voice. A portable voice amplifier is recommended. A number of portable voice amplifiers are

available in the market, but we need to be aware of the specifications, the ratio of decibels, wattage

output to room size, number of people and other factors. With the voice amplifier, voice exercises,

called voice aerobics can augment vocal endurance and stamina.



SYMPOSIUM 8: Skull Base Tumors/ OSA Ballroom B December 1, 2015 (2:30 - 3:30 PM)

HOSPITAL INFORMATION SYSTEM FOR THE FUTURE: SNUBH WAY


Seoul National University Bundang Hospital (SNUBH) had opened at 2003 with

implementation of BESTCare, a fully digitalized hospital information system. SNUBH started with

4 less; chartless, filmless, slipless, and paperless. SNUBH is the first hospital outside the US to

receive the HIMSS Stage 7 accreditation with its home-grown EMR system at 2010. We launched

next generation hospital information system (HIS) BESTCare 2.0 which implemented Saudi Arabia.

The hospital’s award-winning N-Device Strategy deploys health IT in various healthcare settings.

SNUBH SMART Hospital strategy is extremely useful for the doctors, nurses, pharmacists and

administrators and is also very helpful for the patients. N-device based on VDI-system means

any-time, any-where, any-device, which consists of mobile EMR, mobile e-consent, BEST board,

information prescription, SMART bedside station and SMART patient guide and personal health

record.

With clinical data warehouse, big data can easily applicate to medical research and

healthcare outcome. Patient care is also continuously and easily monitored for safety and quality.

In this session, I will introduce the latest SNUBH SMART Hospital solutions.




SUBLINGUAL IMMUNOTHERAPY IN KOREA: PERSPECTIVE FROM

RHINOLOGISTS


The prevalence of allergic rhinitis (AR) in the general population is increasing and

currently estimated to be approximately 10-25%. Although AR is not associated with a risk of

death, the disorder can have a considerable effect on a patient’s quality of life. Consideration of

comorbid diseases, including asthma, nasal polyp, olfactory dysfunction and chronic

rhinosinusitis, results in a tremendous increase in the medical cost for AR treatment, which has

come to entail more than just treating the rhinitis itself.

Majority of patients with AR are diagnosed by ENT specialists or general practice physician

in Asia-Pacific area. The results of the published data suggest that ENT specialists most commonly

encounter patients with AR triggered by one or multiple inhalant allergens. Thus, ENT specialists

are mainly responsible for the primary treament of AR.

Among the current treatment options for AR, specific allergen immunotherapy including

subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) is the only medical

intervention that modifies fundamental immunologic mechanisms by inducing tolerance, and it

can also modify the natural course of the disease.

SLIT has recently received much attention around the world as a primary treatment for AR

and is now widely used as a replacement for subcutaneous administration, even in Korea. The

efficacy and safety of SLIT have been established by many clinical trials, studies, and

meta-analyses, and its long-term effects and prevention of asthma progression have been

suggested.

In this session, I will talk about the SLIT with our reported experiences regarding efficacy,

safety, prevention of progression to asthma, mono-allergen treatment to poly-sensitized patients,

and cost-benefit issues.




INNOVATIONS IN THE DIAGNOSIS & MANAGEMENT OF OSAS


Obstructive Sleep Apnea Syndrome (OSAS) is caused by pharyngeal relaxation during

sleep, resulting in upper airway narrowing and compromised breathing. The number of apneas

and hypopneas per hour of sleep is the AHI. The Gold standard for measuring these events, the

Respiratory Effort (RE), is Oesophageal Pressure (AASM 2007). Moreover, partly compromised

breathing is found to increase the RE, and frequently lead to Arousals from sleep. Harmful

implications like those documented for the apneas/hypopneas are found. Such episodes, named

Respiratory Effort Related Arousals (RERA) are now incorporated in the OSA definition; OSA =

AHI + RERA = RDI, where RDI (Respiratory Distress Index) is the sum of AHI and RERA events

per hour of sleep. (AASM, 2007, 2013)

Incorporation of RERAs increases the number of relatively light OSA sufferers

considerably. Hitherto, use of PSG (PolySomnoGraphy) with EEG (ElectroEncephaloGraphic)

recordings has been used for detecting Arousals. This is no longer necessary.

An innovated algorithm based on measurements of Oesophageal Pressure along with

changes in physiological parameters detecting Arousals, can diagnose RERA and OSA.

A user-friendly device for reliable, fully automatized, complete and cost-effective home diagnosis

for the upgraded OSAS, the ApneaGraph® Spiro (AGS), is developed. The innovations and

practical implications for facilitating the ENT doctor’s diagnostic setup will be described.



SYMPOSIUM 9: Computer Aided Surgery Ballroom A December 2, 2015 (1:30 - 2:30 PM)

IMPROVING OUTCOMES WITH PREOPERATIVE 3D PLANNING & COMPUTER

AIDED SURGERY IN CRANIOMAXILLOFACIAL RECONSTRUCTION

Francis V. Roasa, M.D. (Philippines)

Craniomaxillofacial reconstruction for trauma or oncologic surgery is traditionally planned

using 2 dimensional modalities and operated on using reconstructive techniques that heavily rely

on the surgeon’s experience with intraoperative trial and error, leading to prolonged surgical time.

The slow learning curve inherent to this type of surgery often fails to achieve consistent and

predictable outcomes and this leads to functional and cosmetic deformities that are very difficult to

correct. Preoperative planning using 3-Dimensional Technology and computer-aided surgery has

contributed significantly to improved outcome of major reconstructive craniomaxillofacial surgery

and considerable improvement in operative time. The precise planning and execution of the

reconstruction often leads to restoration of facial symmetry, appearance, and function that are

difficult to achieve by traditional techniques. The use of biocompatible and bioresorbable materials

together with computer printing technology to create scaffolds has opened possibilities for patients

not amenable to having additional surgery for donor harvesting. Future integration of these

scaffolds with the patients’ own cells/tissues and growth factors may provide possibilities wherein

donor harvesting would be a thing of the past. Preoperative 3-D planning and computer-aided

surgery are evolving techniques and will potentially become popular in clinical practice in the

search to achieve accurate, consistent and predictable outcomes in craniomaxillofacial

reconstruction.



SYMPOSIUM 9: Computer Aided Surgery Ballroom A December 2, 2015 (1:30 - 2:30 PM)

IMPROVING OUTCOMES WITH COMPUTER PLANNING AND INTRA

OPERATIVE NAVIGATION IN CRANIOMAXILLOFACIAL SURGERY

Ferdinand G. Pamintuan, M.D. (Philippines)

Preoperative computer design and stereolithographic modeling combined with

intraoperative navigation provide a useful guide for and more accurate reconstruction of a variety

of complex cranio-maxillofacial deformities. Although probably not necessary for routine use,

computer-assisted surgery is indicated for complex posttraumatic or postablative reconstruction of

the orbits, cranium, maxilla, and mandible; temporomandibular, orthognathic surgery. Computer-

assisted preoperative planning and surgery thus advance the difficult surgical field of

craniomaxillofacial cases, particularly through a greater exploitation of radiologic information

without additional radiation to the patient



SYMPOSIUM 10: Pediatric ORL: JNA and Vasculars Tumors Ballroom B December 2, 2015 (1:30 - 2:30 PM)

SURGICAL MANAGEMENT FOR JUVENILE NASOPHARYNGEAL

ANGIOFIBROMA

Lyra V. Veloro, M.D. (Philippines)

Juvenile nasopharyngeal angiofibroma (JNA) is a rare, highly-vascularized benign disease

that is mainly diagnosed in adolescent males. It classically presents with nasal obstruction,

epistaxis and a nasopharyngeal mass. It is considered to originate from the area of the

sphenopalatine foramen and its blood supply is usually from the internal maxillary artery. JNA is

locally invasive and destructive, often involving the nasal cavity, paranasal sinuses, orbit,

pterygomaxillary and infratemporal fossae, cavernous sinus, and cranial fossa.

Contrast-enhanced CT and MR scans as well as an angiogram can help determine diagnosis and

extent of the lesion. Various staging criteria were developed for evaluating JNA although none is

universally accepted. Surgery is considered the treatment of choice in the majority of patients

with JNA. Surgical techniques include open surgical approach, endoscopic surgery, or combined

approaches depending on the stage of the tumor. The current recommendation is to carry out

tumoral embolization prior to proceeding with any of the known surgical techniques.

Understanding the advantages and limitations of these techniques is critical in the surgical

management of patients with JNA.

TREATMENT OPTIONS FOR PEDIATRIC VASCULAR TUMORS OF THE HEAD

AND NECK

Cecilia Gretchen S. Navarro-Locsin, M.D. (Philippines)

Head and neck involvement of vascular tumors ranges from 70%-80%. Over the years

treatment of these lesions has evolved as a result of a greater understanding of the molecular

biology and pathophysiology of the disease plus advances in medical targeted therapy and

surgical techniques. The treatment options available for these tumors will be reviewed. Finally, the

institutional experience on management of these tumors will be discussed and some current

research previewed.



SYMPOSIUM 11: Sleep Ballroom A December 2, 2015 (2:30 - 3:30 PM)

WEARABLE FOR SLEEP

Keith Romeo A. Aguilera, M.D. (Philippines)

EFFECT OF HEAD & NECK CANCER ON SLEEP

Jonalyn Chris T. Ang, M.D. (Philippines)

Patients with cancer complain of sleep disturbances which contribute to decrease quality of

life. In a large questionnaire study of over 900 patients with different types of cancer, fatigue (44%),

insomnia (31%) and excessive sleepiness (28%) were the most prevalent complaints. Sleep

disordered breathing appears to be more frequent in patients with head and neck cancer. It can be

due to the cancer or the effect of cancer treatment.



SYMPOSIUM 12: Current Concepts: COM & Skull Base Surgery Ballroom B December 2, 2015 (2:30 - 3:30 PM)

NHSRC REGISTRY: AN IT MODEL

Ryan Julius Bañez, M.D. (Philippines)

TELEMETRY UNLEASHED: A SINGAPOREAN EXPERIENCE WITH REMOTE

ASSISTANTS IN INTRAOPERATIVE NEURAL RESPONSE TELEMETRY


Neural Response Telemetry or its equivalent has been an important and useful

intra-operative adjunct to a safe and smooth cochlear implantation during implant surgery. This

technology is usually applied in the form of a software program installed in a laptop. This then

communicates via a wire to a speech processor that can be applied directly onto the operation field

magnetically to perform the telemetry. With the advent of wireless technology, there is now the

option of communicating with the speech processor during NRT wirelessly. In this presentation,

we share our early experiences with one such advance. The CR120 Intraoperative Remote Assistant

is now the preferred mode of performing the NRT for all implants from the Cochlear Ltd company.

The feedback from surgeons and audiologists will be compiled and presented.

COCHLEAR IMPLANTS IN SINGLE SIDED DEAFNESS FOR SUDDEN

SENSORINEURAL HEARING LOSS: EARLY FINDINGS OF A SINGAPOREAN

PROSPECTIVE STUDY


The traditional surgical indication for cochlear implantation is in bilateral profound

sensorineural hearing loss. In recent years, there has been evidence to suggest that cochlear

implantation for single sided deafness has significant benefits in terms of sound localisation and

tinnitus control. A prospective study was performed to study the benefits of cochlear implantation

in single sided deafness due to idiopathic sudden sensorineural hearing loss of recent duration less

than 5 years. The early findings of this study is presented in the form of case series discussion and

correlation made with the current published medical literature on this subject.



SYMPOSIUM 13: Plastic Surgery in ORL Ballroom A December 2, 2015 (3:30 - 4:30 PM)

CUTANEOUS SURGERY


Soft tissue surgery is an integral part of ENT. In this presentation, excision, suture

technique, linear closing, and flaps will be addressed as well as scar revision procedures and

dermabrasion . Malignant lesions of the head and neck and Mohs micrographic surgery will also

be discussed.

CREATING A FUNCTIONAL NOSE WITH RHINOPLASTY


An essential element of functional reconstructive nasal surgery is septoplasty. In addition

to this surgical technique, assessment of the profile, nasal tip, and middle vault and their

respective corrective procedures will be discussed.

FACIAL PLASTIC SURGERY OVERVIEW


In facial cosmetic procedures, there are several factors a physician must take into

consideration when planning surgery. Patient classification, knowledge of anatomy, and various

surgical techniques will assist the surgeon in planning for an optimal result. Danger zones, risk

factors, surgical approaches, and post-operative complications of facelift, blepharoplasty, and

forehead lift will be discussed.



SYMPOSIUM 14: Audiology Ballroom B December 2, 2015 (2:30 - 3:30 PM)

STIMULUS CONSIDERATIONS FOR ABR & ASSR RECORDING


Applying a simple delay line cochlear model can explain many known effects of stimulus

selection and parameterization on ABR and ASSR recording. For example, a broadband chirp

evokes stronger ABR responses than a click of the same Hearing Level and higher frequency ASSR

stimuli tend to produce higher responses than lower frequency stimuli. Most of these observations

can be accounted to cochlear mechanics of which examples will be given

IMPACT OF STIMULUS SELECTION ON ABR / ASSR PERFORMANCE

Russell Higgs (United Kingdom)

With examples of live patient recordings the known effects of stimulus selection and

parameterization on ABR and ASSR recordings will be demonstrated.

For example, a broadband chirp evokes stronger ABR responses than a click of the same

Hearing Level and higher frequency ASSR stimuli tend to produce higher responses than lower

frequency stimuli. It is with a greater understanding of these factors that optimized test sequences

can be employed leading to improved results and faster test times.


ABSTRACTS (LUNCH SYMPOSIUM)

LUNCH SYMPOSIUM 2: Ballrooms A & B December 2, 2015 (11:30 AM - 1:00 PM)

SIMPLIFYING LPR DIAGNOSIS & ASSESSMENT OF THERAPY:

THE FILIPINO REFLUX SYMPTOM INDEX

Jose Florencio F. Lapeña Jr., M.D. (Philippines)

Laryngopharyngeal Reflux (LPR) disease affects up to 10% of patients consulting an

otolaryngologist, and is more common in Asians than previously recognized. In addition to diet

and lifestyle modification, LPR is presumptively treated by Proton Pump Inhibitors (PPIs).

Laryngopharyngeal Reflux (LPR) disease can be diagnosed by the Reflux Symptom Index (RSI), as

well as the Reflux Finding Score (RFS) (Belafsky et al., 2002; 2001). Because it is found in more than

50% of patients with hoarseness, it might also be indirectly (albeit partly) diagnosed by the Voice

Handicap Index (VHI) (Jacobson et al., 1997).

Responding to a need for standardized, validated culture-specific versions of these

measures and both the RSI and VHI have been translated into Filipino – the Filipino Reflux

Symptom Index (FRSI) (Lapeña, 2012) and the Filipino Voice Handicap Index (FVHI) (Umali &

Hernandez, 2006)], but the former has not been validated. Establishing the consistency, validity

and reliability of the Filipino Reflux Symptom Index (FRSI) may provide a simple, inexpensive tool

for diagnosis and clinical assessment of therapy that can be used among over 100 million Filipinos

worldwide, particularly in primary health care settings.

This session discusses the results and recommendations of a study aimed to establish the

internal consistency, validity and reliability of the Filipino Reflux Symptom Index (FRSI) among a

sample of Filipino patients and controls, and to test the validated FRSI among a sample of Filipino

patients with Laryngopharyngeal Reflux (LPR) disease before, and after a six-month trial of

Rabeprazole.


FOREIGN SPEAKERS’ DIRECTORY


Attending Surgeon

Memorial Sloan Kettering Cancer Center

1275 York Ave, New York NY 10065

Phone: 212-639-7649

Email: [email protected]


Staff in Oncology Subdivision

ENT Department, Faculty of Medicine,

University of Indonesia, Jakarta

Phone: +62811812363/ +6281291674763


Prof. Marco Caversaccio, M.D.

(Switzerland)

Chairman, Department of ENT - Head &

Neck Surgery

University of Bern, Switzerland

Phone: +41 31 632 29 21


Dominiek Andre Monserez, M.D.

(Netherlands)

Academic Medical Specialist

Erasmus University Medical Center

Rotterdam, Netherlands


Jose Angelito U. Hardillo, M.D., PhD

(Netherlands)

Academic Medical Specialist 8

Erasmus University Medical Center,

Rotterdam, Netherlands

Phone: +31-10-7032688


Prof. Lars Eric Pontus Stierna, M.D., PhD

(Sweden)

Professor and Lecturer

Karolinska Institute and University Hospital

Stockholm, Sweden


Sheng - Po Hao, M.D., FACS, FICS

(Taiwan)

Professor & Chairman

Shin Kong Wu Ho-Su Memorial Hospi-

tal School of Medicine

Fu Jen Catholic University

Taipei, Taiwan

Phone: +886-2-28332211 Ext. 2556



CEO

Spiro Medical AS

Bergen, Norway

Phone: +47 9001 6530



FOREIGN SPEAKERS’ DIRECTORY

Prof. Dr. Robert Baatenburg De Jong

(Netherlands)

Professor and Chairman

Department of Otorhinolaryngology -

Head and Neck Surgery

Erasmus Medical Center, Netherlands

Email:

[email protected]


Director, Center for Hearing & Ear Implants

Singapore General Hospital



Professor

Seoul National University Bundang

Hospital

Seoul, South Korea

Phone: +82-10-3892-6618



R & D Director

PATH Medical GmbH

Germering, Germany

Phone: +49 89 80076502/ +49 176 61241779



Professor

Department of Otolaryngology - Head

and Neck Surgery

University of Tennessee Health Science

Center

Memphis, TN 38163

Phone: 901.233.4374


Russell Higgs (United Kingdom)

International Sales Manager

PATH Medical GmbH

Germering, Germany

Phone: +44 (0) 7720 545950 / +44 (0) 1438 940775



LOCAL SPEAKERS’ DIRECTORY

Alfredo Q.Y. Pontejos Jr., M.D.

Chairman, Dept. of ORL - HNS

UP College of Medicine - Philippine General

Hospital

Tel. No: (02) 526 4360, 554 8467


Philip B. Fullante, M.D.

Clinical Associate Professor


Hospital

Tel. No.: (0922) 851 0986

[email protected]

Johanna Patricia A. Cañal, M.D., MHA

Professor 4


Hospital

Tel. No.: (02) 554 8471


Michael Hussin B. Muin, M.D.

Healthcare IT Consultant

MedProjects, Inc.

Tel. No.: (0928) 554 3435


Ma. Donna Santiago, M.D., MBA

Orbit & Oculoplasty Consultant

FEU - NRMF Medical Center

St. Luke’s Medical Center

Tel. No.: (0922) 899 6352


Jerry Rapes

Managing Director

Amihan Global Strategies Philippines

The Orient Square, F. Ortigas Jr. Road

Tel. No.: (0917) 328 8816


Iris Thiele Isip Tan, M.D., MSc

Professor 3

Medical Informatics Unit

Department of Medicine

UP College of Medicine


Willex Perez

CEO / President

Medcurial Inc.

5F The Orient Square, F. Ortigas Jr. Road


Ivy D. Patdu-Calaquian, M.D., JD

Member & Legal Consultant

Dept. of Health Privacy Experts Group


William L. Lim, M.D.

Asst. Head, Voice, Swallowing & Sinus Center




LOCAL SPEAKERS’ DIRECTORY

Mary Arlene A. Bongosia, M.D.

Consultant


E. Rodriguez Ave., Quezon City

Tel. No.: (02) 723-0301 loc. 5090


Cecilia Gretchen Navarro-Locsin, M.D.

Vice Chairman, Dept. of ORL-HNS


Tel. No.: (02) 723 0108


Jose Florencio F. Lapeña, M.D., MA

Professor 9 of Otorhinolaryngology

University Scientist III


Hospital

Tel. No.: (02) 524 4455, 554 8467


Keith Romeo A. Aguilera, M.D.

Chair, Philippine Academy of Sleep Surgery



Francis V. Roasa, M.D.

Chairman, Dept. of ORL - HNS

University of Santo Tomas Hospital

Tel. No.: (02) 391 6406


Jonalyn Chris T. Ang, M.D.

Active Pediatric Consultant

Dept. of Pediatrics

Cardinal Santos Medical Center

Tel. No.: (02) 661 3669, (0920) 928 0994


Ferdinand G. Pamintuan, M.D.

Chief of Section, Facial Plastic & Reconstruc-

tive & Maxillofacial Trauma

Dept. of ORL-HNS

University of Santo Tomas Hospital


Ryan Julius Bañez, M.D.

Chief Medical Informatics Officer

Ateneo Graduate School of Businness

Healthcare Information & Management Society

[email protected]

Lyra V. Veloro, M.D.

Section Head, Pediatric Otolaryngology

The Medical City

Tel. No.: (02) 635 6789 local 5259



EXHIBITORS’ DIRECTORY

A. MENARINI PHILIPPINES, INC.

4th Floor W Office Building 11th Avenue corner 28th St.

Bonifacio High Street, Bonifacio Global City, Taguig

Phone: (+63 2) 333-3895

Mobile No.: 0915-1143535

E-mail: [email protected]

Ms. Rodalie Grace ‘Bannie’ P. Baluyut

Senior Brand Manager

ABBOTT LABORATORIES

8/F Venice Corporate Center, No. 8 Turin St.

McKinley Town Center, Fort Bonifacio, Taguig City

Phone: (63-2) 822-2688

Fax: (63-2) 894-1071


Ms. Rosette G. Espiritu

CME Associate Officer

ADP PHARMA CORPORATION

23/F The Taipan Place, F.Ortigas Jr. Road

Ortigas Center, Pasig City

Phone: (63-2) 988-2538

Mobile No.: 0920 9882709


Ms. Jenelyn DJ. Eugenio

CME Management Associate

ALL-BIO PHARMA INC.

Unit 1418 & 1419 Cityland Herrera Tower 98

V.A. cor. Rufino St., Salcedo Village, Makati City

Phone: (63-2) 403-3568

Mobile No.: 0926-1064192

E-mail: [email protected]/[email protected]

Ms. Catherine R. Borja

Regulatory Pharmacist

ALLMED INSTRUMENTS MEDICAL SYSTEM (AIMS)

Unit 2A Aiza Building 134 Mindanao Avenue

Brgy. Bahay Toro, Quezon City

Telefax: (63-2) 930-8708

Mobile No.: 0922-8975304


Ms. Rosellyn Mariano

Sales Manager

AMERICAN TECHNOLOGIES INC.

5 Ideal St. Addition Hills Mandaluyong City

Phone: (63-2) 584-0000

Fax: (63-2) 584-6868


Ms. Alma Postrano

Head, Marketing Department

ARCATECH ELECTRONICS / MURACAM

Phone: (63-2) 343-1299


Mobile No.: 0922-8662722

Mr. Ric Villaruz

BAYER CONSUMER CARE

36th Floor, PBCom Tower, Ayala Avenue, Makati City 1209

Phone: (63-2) 448-3895

Mobile No.: 0917-6517984


Mr. Mark Canlas

CME Coordinator

BEAUMED INC.

106 Unit 204 FRDC Bldg., E Rodriguez Jr. Avenue

Ugong, Pasig City

Phone: (63-2) 470-1261

Mobile No.: 0915-9389530


Ms. Jackie Reniedo

Manager

BEROVAN MARKETING INCORPORATED

1526 Rizal Avenue, Sta. Cruz, Manila

Telefax: (63-2) 711-2711

Mobile No.: 0917-3116296

E-mail: [email protected]; [email protected]

Ms. Raquel A. Roa

Business Officer

BIOMEDIS INC.

6/F Dynavision Building, 108 Rada St.

Legaspi Village, Makati City 1229

Fax: (63-2) 812-1252

Mobile No.: 0917-8209035


Mr. Jeremy Ross A. Lim

CMG Specialist

mailto:[email protected]







CELSUS PHARMACEUTICALS PHILS. INC.

115 Scout Rallos corner 11th Jamboree Streets

Sacred Heart, Quezon City 1103

Phone: (63-2) 928-8208

Fax: (63-2) 928-0815

Mobile: 0920-9026548


Mr. Andres G. Fernandez

National Sales Manager

COVIDIEN PHILS. INC. (A MEDTRONIC COMPANY)

Unit 1905-1906 Hanston Square Building

San Miguel Ave., Ortigas Center, Pasig City

Phone: (63-2) 633-8898; 500-3155

Mobile: 0917-8081180


Ms. Rowena Orque

Product Specialist

DENTSTALL TRADING

2111 Legarda St., Quiapo, Manila

Phone: (63-2) 488-3218

Mobile No.: 0916-6677127


Ms. Sherly Cabigting

Owner

DR-KIM (THE BEST HEADLIGHT AND LOUPE IN

THE WORLD)

#213 Ace Gwangmyeong Tower, 108 Haan-ro

Gwangmyeong-si, Gyeoggi-do 423-798 Korea

Phone: +82-2-2611475

Fax: +82-2-26114758

E-mail: [email protected]; Website: www.dr-kim.net

Chris Kim

Manager

DUBBEL MEDICAL CORPORATION

Unit 202 Ablaza Bldg., 117 E. Rodriguez, Sr. Ave.

Quezon City

Fax: (63-2) 740-0713

Mobile: 0922-8696065


Ms. Annabelle A. Jorda

CEO / Chief Finance Manager

EAR DIAGNOSTICS INC.

G/F Cosmopolitan Church corner Apacible

Taft Avenue, Manila

Phone: (63-2) 536-7772; (033) 337-1069

Fax: (63-2) 567-1105


Dr. Rodolfo B. Dela Cruz

President

FERNANDO MEDICAL ENTERPRISES, INC.

MHI Bldg., No. 2-A New York Street

Brgy. Immaculate Conception, Cubao, Quezon City

Phone: (63-2) 727-1521; 727-1532

Mobile No.: 0917-5636797; 0923-5206605


Mr. Sonny D. Feliciano

Sales Manager

FIRST ASSOCIATED MEDICAL DISTRIBUTION CO.,

INC. (FAMED)

FCI Corporate Center, 1814 Philip Street

Multinational Village, Brgy. Moonwalk, Parañaque City

Phone: (63-2) 826-8523

Fax: (63-2) 788-0080

Mobile No.: 0917-8631225


Ms. Jacque M. Eusebio

Sales Manager

GADGETS IN STYLE TRADING CORP.

Unit 625 Shangri-La Plaza, Edsa corner Shaw Blvd.

Mandaluyong City

Phone: (63-2) 352-5500; 959-8854

Mobile No.: 0917-5793355


Mr. William Ordonia

Corporate Sales Supervisor

GETZ PHARMA

2F The Rockwell Business Ctr. Tower 1

Ortigas Avenue, Pasig City

Mobile No.: 0917-8420137


Mr. Jorge Rafael P. Diño

Marketing Specialist




http://www.dr-kim.net







GLAXOSMITHKLINE PHILIPPINES, INC.

2266 Chino Roces Avenue, Makati City

Phone: (63-2) 892-0761

Mobile No.: 0917-8897027


Mr. Charles Arevalo

CME Officer – Allergy & Derma

GREAT RECONSTRUCTION SURGICALS, INC.

Rm. 501-C Culmat Bldg., 1270-1330

E. Rodriguez Sr. Avenue, Quezon City

Telefax: (63-2) 725-0867

Mobile No.: 0917-5411234


Ms. Zeth San Antonio

Corporate Secretary

HEALTHWORLD INTERNATIONAL PHILIPPINES

CORPORATION

421 Quirino Ave., La Huerta, Parañaque City

Phone: (63-2) 829-0175

Fax: (63-2) 826-6770

Mobile No.: 0922-8496753


Ms. Mengie Cabanlit

Sales Manager

HI-EISAI PHARMACEUTICAL INC.

20th Floor Multinational Bancorporation Centre

6805 Ayala Avenue, Makati City

Phone: (63-2) 887-1075

Fax: (63-2) 887-5172

Mobile No.: 0918-9901662


Ms. Macky Quidato / Ms. Cherry V. Balasbas

Senior Product Manager / Marketing Assistant

HOMECARE MEDICAL

1850 Felix Huertas St., Sta. Cruz, Manila

Phone: (63-2) 313-5450; 313-8650; 998-1615

Mobile No.: 0917 6694271; 0943-7075718


Mr. Roy H. Almario

Operations Manager

HYPHENS PHARMA PHILIPPINES, INC.

Unit 3, 2nd Floor GFO Building

#122 Kamuning Road, Quezon City

Phone: (63-2) 927-7505

Fax: (63-2) 927-7506

Mobile: 0917-5583286


Ms. Josiephine Sac-Mantoya

Marketing Manager

INNOGEN PHARMACEUTICALS, INC.

2nd/F MNB Bldg., 124-126 Scout Dr. Lazcano St.

Brgy. Sacred Heart, Quezon City

Phone: (63-2) 410-4613

Fax: (63-2) 374-1842

Mobile: 0932-9116865


Ms. Jacin Reyes

Associate Product Manager

INOVA PHARMACEUTICALS

Unit 2802 Penthouse One Global Place 25th Street

cor. 5th Ave., BGC Taguig City, 1634

Phone: (63-2) 737-5100

Mobile No.: 0917-3285875

Email: [email protected];

[email protected]

Ms. Novelle de Leon-Lopez

Senior Product Manager

INTERMED MARKETING PHILIPPINES, INC.

The Paragon Corporate Centre Industry St.

Madrigal Business Park, Ayala Alabang

Muntinlupa City

Phone: (63-2) 659-0451 to 55

Fax: (63-2) 659-0472


Ms. Liezl L. Abaya

Advertising & Marketing Director IOS MARKETING CORPORATION

647 P. Paterno St., Quiapo, Manila

Phone: (63-2) 733-5445

Fax: (63-2) 733-3767

Mobile No.: 0917-8347912


Ms. Lenlie Villanueva

Sales Head








JOHNSON & JOHNSON PHILIPPINES

Edison Road, Barrio Ibayo, Parañaque City

Phone: (63-2) 824-8845

Mobile No.: 0917-8730395


Ms. Hazel Sering

JULLSURG

WZ-118 Naraina Village, New Delhi-110028, India

Telephone: +91-11-42430347

Mobile: +91-9990659999


Shivam Mahajan

Director

JUSTRIGHT PHARMACEUTICALS

#20 Palanza corner Guirayan Streets

Brgy. Doña Imelda, Quezon City

Phone: (63-2) 413-2367 loc. 108

Fax: (63-2) 412-0533

Mobile No.: 0919-9115391


Mr. John Rex V. Hermoso

Product Manager

LEFORT MEDICAL TRADING CORP.

46 Banahaw St., Cubao, Quezon City

Phone: (63-2) 413-4506

Fax: (63-2) 570-9027

Mobile No.: 0920-9184159


Ms. Lorie Gabiane

Sales Manager

MANILA HEARING AID CENTER

Unit 809, 8th/F Tower A, BSA Twin Tower

Ortigas Center, Mandaluyong City

Telefax: (63-2) 696-1580 loc. 108

Mobile No.: 0906-5898504


Mr. John Paulo G. Dela Cruz

Marketing Associate

MEDTRONIC PHILIPPINES, INC.

Unit 810, 8th/F Sun Life Centre, 5th Avenue

Cor. Rizal Drive, Bonifacio Global City, Taguig City

Phone: (63-2) 403-5519 loc. 303

Mobile No.: 0917-7149585; 0922-8171974


Mr. Marcel C. Ingalla

Market Development Specialist

MICROLAB

1157 Rodriguez Avenue, cor. Heneral Lacuña St.

Bangkal, Makati City

Phone: (63-2) 551-3839

Fax: (63-2) 831-9621

Mobile: 0917-8172825


Mr. Navarre M. Espinoza

Sales Representative

NATRAPHARM

The Patriot Bldg. Km. 18 West Service Road

SLEX, Sucat, Parañaque City

Phone: (63-2) 821-7382

Mobile No.: 0917-8747527


Mr. Ferdinand Carmelo F. Samson

Associate Product Manager

NEW MARKETLINK PHARMACEUTICAL CORP.

(ORAHEX)

2nd Floor The Corporate Centre

2291 Don Chino Roces Ave. Ext., Makati City

Phone: (63-2) 836-5838 to 47

Fax: (63-2) 976-9044

Mobile: 0917-8797605 / 0917-8544061


Mr. Eugenio Santos / Mr. Gilbert Espiritu

Sales and Marketing Managers

OLTEN INSTRUMENTS PHILS. CORP.

No.16 Sampaguita St., Tomasa Subd., Ususan, Taguig City

Phone: (63-2) 628-3293

Fax: (63-2) 641-9150

Mobile No.: 0917-5514990


Ms. Ruth L. Tee

Sales Manager






ONE PHARMA COMPANY, INC.

Abel Nosce St., BF Resort Village, Las Piñas City

Phone: (63-2) 871- 2941


Ms. Jane Natividad

Marketing Administrator

PFIZER, INC.

23F Ayala Life FGU Center, 6811

Ayala Avenue, Makati City

Phone :( 63-2) 451-9200

Mobile No.: 0917-5205091


Website: www.pfizer.com.ph

Mr. Carlo Jose Garcia

Country Portfolio Manager

PHAREX HEALTH CORP

Units 101-102, G/F Bldg. Alpha UP-Ayala Land TechnoHub

Commonwealth Ave., Diliman, Quezon City

Fax: (63-2) 433-8088

Mobile No.: 0998-9614001


Mr. Erik Viray

Corporate Relations Manager - Events

PINES MEDICAL TRADING

14 A Sunflower St, San Luis Village, Baguio City

Phone: (074) 442-2293

Mobile No.: 0917-6870081


Ms. Jonah W. Deyto

Proprietress

RECKITT BENCKISER (RB) HEALTHCARE

PHILIPPINES INC.

Unit 2202 One Global Place, 5th Ave. cor. 25th St.

Bonifacio Global City, Taguig 1634

Phone: (63-2) 889-5823 loc. 705

Fax: (63-2) 889-6293

Mobile No.: 0917-3284535


Ms. Evangeline “Vangee” F. Reyes

Medical Marketing Manager, Phils.

RESWERKES PHILS., INC.

Unit 1001 The Orient Square Building

F. Ortigas, Jr. Rd., Ortigas Center, Pasig City

Phone: (63-2) 470-2931

Fax: (63-2) 470-2809

Mobile No.: 0927-3044038


Ms. Kathy Dalimocon

Sales Specialist

SANDOZ PHILIPPINES CORP.

7th Floor ARCC Bldg., Gamboa and Salcedo Sts.

Legaspi Village, Makati City

Phone: (63-2) 368-7888

Fax: (63-2) 815-0101

Mobile No.: 0917-8487808


Ms. Rhoda Delos Reyes

Product Manager

SAVIOUR MEDEVICES INC.

2nd Flr. Global Ent. Bldg., 138 HV Dela Costa St.

Salcedo Village, Makati City

Phone: (63-2) 812-7768

Fax: (63-2) 845-2516

Mobile No.: 0922-9091158


Ms. Cristina L. Adan

Executive Vice President

SENSOMED PHILIPPINES, INC.

Unit 1508 Orient Square Bldg., F. Ortigas Jr. Road

Ortigas Center, Pasig City

Phone: (63-2) 635-5169

Fax: (63-2) 635-5170

Mobile No.: 0917-2713339


Dr. Natividad N. Arriola

President & CEO

SONUS MANILA HEARING CARE CENTER

Unit 2205, 22nd Floor Jollibee Plaza Condominium Corp.

Emerald Avenue, Ortigas Center, Pasig City

Phone: (63-2) 654-2843 / 654-5935

Mobile No.: 0932-8808012 / 0932-8808054

E-mail: [email protected] /[email protected]

Mr. Carlo Turda / Mr. Ronie Eustaquio

Owners & Managing Directors






TAKEDA HEALTHCARE (PHILIPPINES) INC.

17th Floor, Zuellig Bldg. corner Paseo de Roxas

Makati Avenue, Makati City

Phone: (63-2) 575-0064

Fax: (63-2) 575-0080


Ms. Camille Reyes

Associate Professional Healthcare Services Manager

THE CATHAY DRUG COMPANY INC.

2/F Vernida 1 Bldg., 120 Amorsolo St.


Phone: (63-2) 892-5936

Fax: (63-2) 818-6739

Mobile No.: 0917-8812978


Ms. Maria Agnes Ramos

CME Coordinator

TOPBOOKS HEALTH INFORMATION PROVIDER

INC.

Unit 6015 Golden Rock Bldg., 168 Salcedo St.


Telefax: (63-2) 843-0082

Mobile No.: 0920-9693572


Mr. Tim Lum

Manager

UNITED AMERICAN PHARMACEUTICALS, INC.

132 Pioneer Street LVP Compound, Mandaluyong City

Phone: (63-2) 858-1000

Fax: (63-2) 635-3581

Email: [email protected]; acesguer-

[email protected]

Mr. Rinaldo C. Enriquez

Mr. Alvin Cruz-Esguerra

UAP-Product Management Group

UNITED LABORATORIES, INC.

#66 United St., Mandaluyong City

Phone: (63-2) 858-1000 local 1970


Website: www.unilab.com.ph

Mr. Rainier S. Herradura

Professional Relations Management Division

URGO-VIVA SANTE PHILIPPINES

Metro Drug Office, Taguig City

Mobile No.: 0917-5239440


Website: www.vivasante.com

Mr. David P. Perianes III

Product Manager

VARIANCE TRADING CORPORATION

57-A Maliksi St., Brgy. Pinyahan, Quezon City

Fax: (63-2) 990-0600

Mobile No.: 0925-3653873


Ms. Reina Valerie C. Maglinte

Business Development Manager

VOLVO NORTH EDSA

Phone: (63-2) 376-4965

Mobile No.: 0917-8118165

Mr. Doy Montemayor

Branch Manager

WESTMONT PHARMACEUTICALS

4th Floor, Bonaventure Plaza, Ortigas Avenue

Greenhills, San Juan City

Phone: (63-2) 858-1277

Mobile: 0917-8209625


Ms. Jennifer Lim

CME Officer

ZYDUS HEALTHCARE PHILS., INC.

9/F Eco Tower, 9th Avenue cor. 32nd Streets

Bonifacio Global City, Taguig

Mobile No.: 0917-8250550


Ms. Caroline T. Lim

BDM



http://www.unilab.com.ph


http://www.vivasante.com


SPONSORS & EXHIBITORS BOOTH LAYOUT

COMPANY NAME FOYER

UNILAB / UAP F1

A. MENARINI PHILIPPINES, INC. F2

BIOMEDIS F3

HI-EISAI F4

SANDOZ PHILIPPINES CORP. F5

NATRAPHARM, INC. F6

DR-KIM F7

ABBOTT PRODUCTS PHILS., INC. F8

COMPANY NAME BOOTH NO.

JOHNSON & JOHNSON PHILS., INC. B1

INOVA PHARMACEUTICALS B2

VOLVO NORTH EDSA B3

GLAXOSMITHLINE PHILS., INC. B4

ADP PHARMA CORP. B5

THE CATHAY DRUG CO., INC. B6

JUSTRIGHT PHARMACEUTICALS B7

NEW MARKETLINK PHARMA CORP. (ORAHEX) B8 & B9

ZYDUS HEALTHCARE PHILS., INC. B10

BEAUMED, INC. B11

DUBBEL MEDICAL CORPORATION B12 & B13

TOPBOOKS B14

GLAMOURBOX BOUTIQUE B15

CITIBANK B16


SPONSORS’/ EXHIBITORS’ BOOTH LAYOUT


MANULIFE B17

GADGETS IN STYLE TRADING CORP. B18 & B19

HEALTHWORLD B20

HOMECARE MEDICAL B21

ARCATECH / MURACAM B22

SONUS MANILA HEARING CARE CENTER B23

EAR DIAGNOSTICS, INC. B24

ONE PHARMA COMPANY, INC. B25

TAKEDA HEALTHCARE PHILS., INC. B26

ALL-BIO PHARMA, INC. B27

PHAREX HEALTH CORP. B28

RECKITT BENCKISER HEALTHCARE PHILS., INC. B29

GETZ PHARMA PHILS INC. B30

HYPHENS PHARMA PHILIPPINES, INC. B31

PFIZER, INC. B32

WESTMONT PHARMACEUTICALS, INC. B33

CELSUS PHARMACEUTICALS PHILS. INC. B34

BAYER CONSUMER CARE B35 & B36

INTERMED MARKETING PHILS., INC. B37


INNOGEN PHARMACEUTICALS, INC. B40

VARIANCE TRADING CORPORATION B41 & B42

RESWERKES B43

ALLMED INSTRUMENTS MEDICAL SYSTEM B44

FAMED B45

DENTSTALL TRADING B46

IOS MARKETING CORPORATION B47 & B48

PINES MEDICAL TRADING B49

MANILA HEARING AID B50

OLTEN INSTRUMENTS PHILS. CORP. B51 & B52

SAVIOUR MEDEVICES, INC. B53

GREAT RECONSTRUCTION SURGICALS, INC. B54

MEDTRONIC PHILIPPINES, INC. B55

COVIDIEN PHILIPPINES, INC. B56

JULLSURG B57

LEFORT MEDICAL TRADING CORP. B58

AMERICAN TECHNOLOGIES INC. B59

PPD/THE FILIPINODOCTOR.COM B60

MICROLAB INC. B61 & B62

BEROVAN MARKETING INC. B63

FERNANDO MEDICAL ENTERPRISES, INC. B64

URGO-VIVA SANTE B38

SENSOMED PHILS., INC. B39


ACKNOWLEDGEMENT

Secretariat Publication & Documentation Committee

pso hns 59 annual convention & 1 philippine international ... · messages v y- v ^ ... people...

Documents